USRE45068E1 - Aerosol delivery apparatus - Google Patents

Aerosol delivery apparatus Download PDF

Info

Publication number
USRE45068E1
USRE45068E1 US13/371,787 US201213371787A USRE45068E US RE45068 E1 USRE45068 E1 US RE45068E1 US 201213371787 A US201213371787 A US 201213371787A US RE45068 E USRE45068 E US RE45068E
Authority
US
United States
Prior art keywords
mouthpiece
window
flow control
system interface
control member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US13/371,787
Inventor
James N. Schmidt
Daniel Engelbreth
Rick Blacker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trudell Medical International
Original Assignee
Trudell Medical International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trudell Medical International filed Critical Trudell Medical International
Priority to US13/371,787 priority Critical patent/USRE45068E1/en
Priority to US14/340,146 priority patent/USRE46050E1/en
Application granted granted Critical
Publication of USRE45068E1 publication Critical patent/USRE45068E1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0013Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0016Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0018Details of inhalators; Constructional features thereof with exhalation check valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816Joints or connectors
    • A61M16/0841Joints or connectors for sampling
    • A61M16/0858Pressure sampling ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20Valves specially adapted to medical respiratory devices
    • A61M16/208Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
    • AHUMAN NECESSITIES
    • A63SPORTS; GAMES; AMUSEMENTS
    • A63BAPPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B23/00Exercising apparatus specially adapted for particular parts of the body
    • A63B23/18Exercising apparatus specially adapted for particular parts of the body for improving respiratory function
    • AHUMAN NECESSITIES
    • A63SPORTS; GAMES; AMUSEMENTS
    • A63BAPPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B2208/00Characteristics or parameters related to the user or player
    • A63B2208/12Characteristics or parameters related to the user or player specially adapted for children

Definitions

  • the invention relates to an apparatus and method for performing Positive Expiratory Pressure (PEP) therapy. More particularly, this invention relates to a method and apparatus for performing PEP therapy alone or in conjunction with an aerosol delivery apparatus.
  • PEP Positive Expiratory Pressure
  • PEP therapy is used primarily in pulmonary secretion removal.
  • Devices used to perform PEP therapy provide positive pressure during expiration.
  • the patient or user exhales against a fixed orifice resistor and generates a pressure ranging approximately from 10-20 cm H 2 O.
  • the resistance orifice is an important consideration and frequently is initially set by a physician, veterinarian, or a skilled practitioner in the art. An orifice that is too large may result in a short exhalation that will not produce proper expiratory pressure. An orifice that is too small may result in a longer expiratory phase that raises the pressure above approximately 20 cm H 2 O and ultimately increases the work of breathing.
  • the airway is splinted open by the pressure. This causes the movement of secretions from the peripheral airways into the larger airways where they can be expelled.
  • PEP therapy usually lasts for about 10-20 minutes and is performed as required, generally 1-4 times per day. Typically, the patient performs 10-20 PEP breaths, removes the device from their mouth and follows this with a forceful exhalation. This final exhalation triggers a cough that loosens secretions.
  • an inhaled substance such as, but not limited to, a medicine or remedy.
  • aerosol delivery apparatus means any apparatus capable of producing and/or delivering a substance, such as, but not limited to, a medicine, in a form suitable for inhalation by a patient and includes, without limitation, an aerosol holding chamber, nebulizer, spacer with integrated actuator, a dry powder inhaler, and a metered dose inhaler.
  • One aspect of the present invention is directed to a positive respiratory pressure apparatus including a patient respiratory system interface and a valve assembly in fluid communication with the patient respiratory system interface.
  • the valve assembly has a valve configured to pass a fluid traveling in a predetermined direction from a first side to a second side of the valve, and a variable resistance bypass window positioned adjacent the valve and having a resistance to a fluid traveling in a direction opposed to the predetermined direction, where the variable resistance bypass window is continuously adjustable between a first fluid resistance and a second fluid resistance.
  • an apparatus is disclosed that is capable of performing positive expiratory pressure (PEP) therapy alone or in combination with providing a substance, generally in aerosol form.
  • the apparatus includes a positive pressure (PP) valve having a continuously variable respiratory window.
  • PP positive pressure
  • the term respiratory is intended to encompass both inhalation and exhalation. Whether inhalation resistance or exhalation resistance is called for will be known to one skilled in the art.
  • the valve may be located at or near the output end of an aerosol delivery apparatus.
  • the PP apparatus is associated with a mask.
  • the mask with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus.
  • the PP apparatus is associated with a mouthpiece.
  • the mouthpiece with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus.
  • the PP apparatus is associated with a nebulizer.
  • the nebulizer with the PP apparatus may be used alone or in combination with a patient respiratory system interface, such as a mask or mouthpiece.
  • the PP apparatus is associated with a spacer chamber with an integrated actuator.
  • the spacer chamber with the integrated actuator associated with the PP apparatus may be used alone or in combination with a mouthpiece or mask.
  • a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber having a PP valve associated therewith.
  • a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber engageable with a mouthpiece or mask having a PP valve associated therewith.
  • kits for performing positive expiratory pressure including an aerosol delivery apparatus, a mouthpiece and/or mask attachable to the output end of the aerosol delivery apparatus, and a PP apparatus.
  • the PP apparatus may be located on the aerosol delivery apparatus or the mouthpiece and/or mask.
  • the PP apparatus may be attached to the aerosol delivery apparatus or integrally formed with the apparatus.
  • the aerosol delivery apparatus, mouthpiece, and PP valve can be combined so as to accomplish positive expiratory therapy and administration of a substance, such as, but not limited to, a medicine in aerosol form. Any aerosol delivery apparatus may be used.
  • a backpiece is included for association with an aerosol delivery apparatus.
  • a pressurized metered dose inhaler can engage with the backpiece for delivery of a medicament.
  • One embodiment of a method of performing positive expiratory pressure therapy includes providing a PP apparatus with a valve that is capable of providing a continuously variable expiratory window. The method further includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a substance, such as a medicament, may be provided for inhalation into the respiratory system.
  • the PP valve may be positioned so as to provide positive inspiratory pressure upon inhalation into the apparatus.
  • a further aspect of another embodiment includes association of a PP apparatus associable with a mask or mouthpiece engageable with a backpiece device.
  • the backpiece device includes a plastic or an elastomeric adapter suited to receive the mouthpiece of a pressurized metered dose inhaler.
  • One embodiment of a method of performing positive expiratory pressure therapy includes providing a positive expiratory pressure apparatus having a valve capable of providing a continuously variable resistance window, performing a series of breaths including inhalation and exhalation; exhaling so that the exhalant is directed through the continuously variable resistance window, performing a therapeutic cough triggering the loosening of secretions, and providing an inhaleable medicament.
  • Another embodiment of a method of performing positive expiratory pressure therapy includes providing a positive respiratory pressure apparatus having a valve capable of providing a continuously adjustable resistance to exhalation, where the valve is located in a mouthpiece attachable to a chamber.
  • a patient then executes a series of therapeutic breaths, including inhalation and exhalation, wherein the exhalant is directed through the continuously adjustable resistance window, the patient performs a therapeutic cough triggering the loosening of secretions, and medicament is provided via the chamber.
  • a method of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes providing a positive expiratory pressure apparatus having a positive expiratory pressure valve capable of providing a continuously variable resistance window, where the valve is positionable in a mouthpiece and the mouthpiece attachable to an aerosol holding chamber. A series of therapeutic breaths, including inhalation and exhalation, are then taken where the exhalant is directed through the continuously variable resistance window.
  • the continuously variable resistance window is preferably capable of providing a variable back pressure to the exhalant.
  • a therapeutic cough capable of triggering the loosening of sections is performed and aerosolized medicament from the aerosol holding chamber is administered through inhalation.
  • One embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; and an aerosol holding chamber having an output end, the positive respiratory pressure valve locatable at the output end.
  • Yet another embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; an aerosol holding chamber having an input end and an output end, the positive respiratory pressure valve locatable at the output end; and a metered dose inhaler canister capable of association with the input end of the aerosol holding chamber.
  • a still further embodiment of a kit for performing positive expiratory pressure includes an aerosol holding chamber having an inlet and an outlet.
  • a backpiece is attachable to the inlet of the aerosol holding chamber with a metered dose inhaler capable of association with the backpiece.
  • a mouthpiece is attachable to the outlet of the aerosol holding chamber.
  • a positive expiratory pressure valve is generally locatable at the outlet end of the aerosol holding chamber, wherein the aerosol holding chamber, backpiece, mouthpiece, and positive expiratory pressure valve can be combined so as to accomplish positive expiratory therapy and administration of an aerosolized medicament.
  • An additional embodiment of an apparatus capable of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes a positive expiratory pressure valve having a continuously variable resistance window, a mouthpiece, the positive expiratory pressure valve associable with the mouthpiece, and a nebulizer having an input end and an output end, the positive expiratory pressure valve associable with the output end.
  • FIG. 1 is a cross sectional view of a mouthpiece associable with a chamber in conjunction with a PP apparatus.
  • FIG. 2 is a perspective view of a mouthpiece associable with a chamber in conjunction with the PP apparatus.
  • FIG. 3 is an exploded view of the preferred embodiment.
  • FIG. 4a is a front view of one embodiment of the PP apparatus.
  • FIG. 4b is a cross section drawn along line A-A of FIG. 4a .
  • FIG. 4c is a back view of one embodiment of the PP apparatus.
  • FIG. 4d is a cross section drawn along line B-B of FIG. 4a .
  • FIG. 4e is a sectional cross section drawn along line C-C of FIG. 4a .
  • FIG. 4f is a rear perspective view of the embodiment of FIG. 4a .
  • FIG. 5 is a rear perspective of a mouthpiece according to a preferred embodiment.
  • FIG. 6 is a front perspective view of a mouthpiece with one embodiment of the PP apparatus.
  • FIG. 7a is a front view of the fitting and manometer port.
  • FIG. 7b is a cross section drawn along line A-A of FIG. 7a of the fitting and port.
  • FIG. 8a is a top view of one embodiment of the slide control.
  • FIG. 8b is a side view of one embodiment of the slide control.
  • FIG. 8c is a perspective view of one embodiment of the slide control.
  • FIG. 8d is a cross section drawn along line A-A of FIG. 8a .
  • FIG. 9 is a top perspective view of one embodiment of the slide control.
  • FIG. 10 is a perspective view of an alternative embodiment of the PP apparatus of FIGS. 1-3 showing detent notches in conjunction with a mouthpiece.
  • FIG. 11 is an exploded view of one embodiment showing a slide control having a port.
  • FIG. 12 is one embodiment of the slide control having a port.
  • FIG. 13 is one embodiment of the mouthpiece showing the annular sealing ring.
  • FIG. 14 is one embodiment showing a plurality of detent notches.
  • FIG. 15 is a side view of one embodiment of the control valve showing the port.
  • FIG. 16 is a concave perspective view of the slide control showing the port.
  • FIG. 17 is a concave bottom view of the slide control showing the port.
  • FIG. 18 is an exploded view of an alternative embodiment of the PP apparatus of FIGS. 8-10 .
  • FIG. 19 is a cross-sectional view of the PP apparatus of FIG. 18 .
  • FIG. 20 is a perspective view of a duck-bill valve used in the PP apparatus of FIGS. 18-19 .
  • FIG. 21 is a cross-sectional view of the duck-bill valve of FIG. 20 .
  • FIG. 22a is a front exploded view of one embodiment of the PP apparatus in conjunction with a mouthpiece and associable with a spacer.
  • FIG. 22b is a rear exploded view of one embodiment of the PP apparatus in conjunction with a mouthpiece and associable with a spacer.
  • FIG. 22c is a front view of one embodiment of a valve showing the baffle.
  • FIG. 23 is a perspective view of one embodiment of a PP apparatus in association with a nebulizer.
  • FIG. 24 is an exploded view of one embodiment of the PP apparatus and a mouthpiece.
  • FIG. 25 is a perspective view of one embodiment of the PP apparatus in an open position and a mouthpiece.
  • FIG. 26 is a perspective view of one embodiment of the PP apparatus in a semi-open position and a mouthpiece.
  • FIG. 27 is an exploded view of one embodiment of the PP apparatus showing the disc and a mouthpiece.
  • FIG. 28a is a top view of one embodiment of the PP apparatus and a mouthpiece.
  • FIG. 28b is a cross section of one embodiment of the PP apparatus and a mouthpiece showing a plurality of prongs holding the PP apparatus.
  • FIG. 29 is an exploded view of a PP apparatus associated with a mouthpiece and having an inhalation valve.
  • FIG. 30 is an exploded view of a PP apparatus associated with a mouthpiece and having an exhalation valve.
  • FIG. 31 is a further perspective view of one embodiment of the PP apparatus in conjunction with a mask having an opening for association with a chamber.
  • FIG. 32a is a close up of one embodiment of the PP apparatus in a fully open position in conjunction with a mask.
  • FIG. 32b is a cross section of one embodiment of the PP apparatus in a fully open position in conjunction with a mask.
  • FIG. 33a is a close up of one embodiment of the PP apparatus in a partially open position in conjunction with a mask.
  • FIG. 33b is a cross section of one embodiment of the PP apparatus in a partially open position in conjunction with a mask.
  • FIG. 34a is a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
  • FIG. 34b is a cross section of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
  • FIG. 35a is a front exploded view of a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
  • FIG. 35b is a rear exploded view of a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
  • FIG. 36 is a front view of one embodiment of the PP apparatus showing resistance setting indicia.
  • FIG. 37 shows a perspective view of a spacer for a pressurized metered dose inhaler with one embodiment of the PP apparatus.
  • FIG. 38a is a perspective view of one embodiment of the resistance window in the open position.
  • FIG. 38b is a perspective view of the embodiment of FIG. 38a with the resistance window in a closed position.
  • FIG. 39a is a perspective view of one embodiment of the resistance window in the open position.
  • FIG. 39b is a perspective view of one embodiment of the resistance window in the closed position.
  • FIG. 40 illustrates an alternative embodiment of the apparatus of FIGS. 37-39 .
  • FIGS. 1-3 show one embodiment of an assembly 10 for performing positive expiratory pressure (PEP) therapy where the assembly incorporates a positive pressure (PP) device having a PP valve 12 .
  • the assembly 10 includes an aerosol delivery apparatus, such as an aerosol holding chamber 14 , and a patient respiratory system interface, such as a mouthpiece 16 and/or mask attachable to the output end of the aerosol delivery apparatus.
  • the PP valve 12 may be located on the aerosol delivery apparatus or the patient respiratory system interface.
  • the assembly 10 combines the aerosol delivery apparatus, mouthpiece, and PP valve into a tool for use in both positive expiratory therapy and administration of a substance, such as a medicament, in aerosol form. Any aerosol delivery apparatus suitable for generating an aerosol of the desired substance may be used.
  • a backpiece 18 is attachable to the inlet 20 of the aerosol holding chamber 14 .
  • a metered dose inhaler (not shown) may be connected with the backpiece 18 .
  • the mouthpiece 16 is attachable to the outlet end 22 of the aerosol holding chamber 14 .
  • the PP valve 12 is generally locatable at the outlet end 22 of the aerosol holding chamber 14 .
  • FIG. 3 depicts an exploded view of the PEP assembly showing an annular valve 24 positioned between the outlet end 22 and the mouthpiece 16 . More details on the aerosol holding chamber 14 disclosed in FIGS. 1-3 may be found in U.S. Pat. No. 4,470,412 and U.S. patent application Ser. No. 09/287,997 incorporated above.
  • the aerosol holding chamber 14 is provided with an annular valve 24 located at its outlet end 22 .
  • the annular valve 24 allows the user to inhale medicament from the chamber 14 , but prevents exhalation back through the chamber.
  • a PP valve 12 may be formed in a mouthpiece 16 .
  • the PP valve 12 includes a slide control 26 that is movably positioned relative to a resistance window 28 .
  • the slide control 26 is variably maneuverable to cover or uncover the resistance window 28 in a continuous manner. Further, the movement of the slide control 26 includes, but is not limited to, covering or uncovering, and/or opening or closing, the resistance window 28 or any variations thereof.
  • the PP valve 12 may be located on or in conjunction with a mouthpiece 16 .
  • An exemplary embodiment of the mouthpiece 16 shown in FIGS. 4a-4f has a distal end 30 and a proximal end 32 .
  • the proximal end 32 of the mouthpiece is inserted or associated with the mouth or nostrils of the user.
  • the distal end 30 of a mouthpiece may or may not be associated with an aerosol delivery apparatus and the mouthpiece alone may be configured to constitute a PEP device.
  • the PP valve 12 may be located at or near the distal end 30 of the mouthpiece 16 . Although, it is understood that the PP valve 12 may be located anywhere on the mouthpiece 1 and its location is not to be limited. In an alternative embodiment, the PP valve 12 may be located at or near the output end 20 of the aerosol delivery apparatus, such as, but not limited to, the aerosol holding chamber 14 of FIGS. 1-3 .
  • the direction of travel of any fluid, particularly an aerosol or nebulizer medicament is in the direction from the input end 20 , through the channel or chamber body, and to or out the output end 22 . This direction of travel from input end 20 to output end 22 is referred to as travel from downstream to upstream.
  • the mouthpiece 16 is formed of plastic.
  • the plastic may be either rigid or soft.
  • Other materials that can also be used for the mouthpiece 16 include metal or other materials known to one in the art.
  • a tab 34 is provided allowing for the connection of a cap 36 , as shown in FIG. 2 , to cover the proximal end 32 of the mouthpiece 16 .
  • the mouthpiece 16 may include indicia 35 , or setting indications, representing the resistance setting.
  • the indicia 35 may be in the form of numbers, bars, colors, a series of dots or the like.
  • the PP apparatus 10 may includes a fitting 39 sized for placement over the proximal end of the mouthpiece.
  • the fitting 39 includes a manometer port 41 extending from the fitting over which a manometer can be attached.
  • the fitting 39 is formed of a plastic.
  • the plastic may be either rigid or soft. Other materials that can also be used to form the fitting include metal.
  • FIGS. 3 , 8 a- 8 d and 9 show an embodiment of the slide control 26 of the PP apparatus 10 .
  • the slide control 26 is of a semi-circular, quarter moon shape.
  • the slide control 26 has a first lateral side 38 concave in shape and a second lateral side 40 opposite the first side 38 .
  • the slide control 26 also has a top 42 and a bottom 44 surface. From the top surface 42 of the slide control 26 extends a tab setting 46 .
  • the tab setting 46 is a uniformly molded projection from the slide control 26 .
  • the tab setting 46 has smooth edges for easy engagement with the finger, thumb or appendix of the user.
  • the tab setting 46 may also have a serrated edge or any other edge known in the art.
  • the tab setting 46 projects through the mouthpiece from the tab window 48 .
  • the user of the device manipulates the tab setting 46 in such a manner as to cause, either directly or indirectly, the movement of the slide control 26 thereby varying the opening of the resistance window 28 .
  • the tab window 48 is arcuate in shape, parallel to the contour of the circumference of the mouthpiece 16 .
  • the slide control 26 is preferably seated in a channel 50 located on the mouthpiece 16 .
  • the slide control 26 is held within the channel 50 by at least one tooth 52 .
  • Located on one or both of the walls of the channel 50 is a stepped surface 54 as shown in FIG. 5 .
  • the control arm 56 of the slide control 26 is shown having a finger protection 58 from one end of the slide control 26 .
  • the slide control 26 may have a control arm 56 located on both ends of the slide control 26 .
  • the finger projection 58 is capable of engagement with the stepped surface 54 inside the mouthpiece shown in FIGS. 4c and 5 .
  • the stepped surface 54 includes a series of ribs extending a variable length of the internal diameter of the mouthpiece 16 .
  • the stepped surface 54 may also be located along the tab window 48 . Therefore, the location of the stepped surface 54 may vary while remaining engageable by the control arm 56 .
  • the stepped surface 54 may be located on either or both of the internal walls of the channel 46 .
  • the slide control 26 is of a flexible material so that the control arm 56 can slide across the uppermost surface of the ribs projecting from the stepped surface 54 .
  • the control arm 56 engages in a semi-locked manner the ribs projecting from the stepped surface 54 .
  • the end of the slide control 26 opposite the control arm 56 may either be provided with a finger projection 58 or may be smooth.
  • the length of the slide control 26 extending from the tab setting 46 to the end of the control arm 56 opposite the projection 58 is generally the length of the resistance window 28 .
  • This resistance control length 60 is at least the length that the resistance window 28 can be opened allowing for exhalant to exit the window 28 .
  • the slide control 26 is manufactured of a plastic.
  • the plastic may be either rigid or soft.
  • Other materials that can also be used for the slide control 26 include metal or other materials known in the art.
  • the resistance window 28 may be an opening of any size or shape in the walls defining the channel 46 in the mouthpiece 16 which, in conjunction with the illustrated embodiment of the slide control 26 , provides an opening in the mouthpiece 16 to produce sufficient pressure during exhalation of the patient performing PEP therapy.
  • the resistance window 28 may be formed with straight or slanted edges. If the edges are slanted, this provides a steeped effect to the resistance window 28 . If the desired exhalation pressure is determined to range from 10-20 cm H 2 O, then the resistance window 28 in conjunction with the slide control 26 , acting as a cover or closure mechanism for the resistance window 28 , are sized in such a manner as to provide an appropriate opening for the desired exhalation pressure to be produced.
  • the length of the window may be of a longer length so as to provide a large enough opening through which PEP therapy is performed.
  • the resistance window length 60 of the control arm 26 is generally longer to cover the desired amount of the resistance window 28 .
  • the control arm 26 may provide a continuously adjustable variable resistance window between a first position where the control arm completely blocks the window 28 , to a second position where the control arm leaves the window completely open.
  • FIGS. 10-17 An alternative embodiment of an assembly 100 for performing PEP therapy is shown in FIGS. 10-17 .
  • This embodiment is similar to the embodiment of FIGS. 11-13 , but utilizes a variation of the resistance window and slide control in the PP valve 112 .
  • the resistance window 128 and slide control 126 are positioned in the mouthpiece 116 .
  • the tab setting 146 of the slide control 126 is of a flexible material.
  • a detent 158 protrudes from the first tab setting face 156 located on the concave side 125 of the slide control 126 .
  • a position indicating rib 159 is located on the tab setting 146 opposite the detent 158 .
  • the rib 159 is shown as a generally rectangular protrusion from the surface of the tab setting 146 .
  • the rib 159 may be any shape protrusion, such as but not limited to circular, triangular.
  • the rib 159 may not be a protrusion at all but rather is a concave marking on the surface of the tab setting 146 .
  • the rib 159 has at least the function of indicating to the user the extent of the opening of the resistance window 128 . Therefore, one skilled in the art can envision a variety of marking, shapes, indents or protrusions, or colors which serve at least the function of indicating the extent of the opening of the resistance window 28 .
  • the detent 158 located on the tab setting 146 is associated with at least one detent notch 154 as shown in FIGS. 10 and 14 .
  • the flexible tab setting 146 is movable within the tab window 148 .
  • the one or more detent notches 154 are preferably located along the boundary of the tab window 148 and indicia 135 , representative of exhalation effort corresponding to the position of the slide control 126 , are arranged adjacent the respective detent positions.
  • FIGS. 10 and 14 show a plurality of detent notches 154 .
  • the flexible tab setting 146 is moved along the tab window 148 .
  • the detent 154 located on the first tab fitting face 125 of the tab setting 146 moves into and out of engagement with the detent notches 154 .
  • Movement along the boundary and engagement with the detent notches 154 removably fixes the slide control 126 in a variety of positions. Each varied position provides for a further opening or closing of the resistance window 128 .
  • the detent 158 is not limited to being engaged with a detent notch but may be engaged or seated at any point along the boundary. Engagement with, or seating within, a detent notch 154 of a detent 158 provides for a variable securely fixed opening of the resistance window 128 .
  • Each detent notch 154 may correspond to a particular size opening or pre-set opening of the resistance window 128 . Therefore, by engagement of the detent 158 within the detent notch 154 , the user may be provided with a preset resistance window opening 128 . Yet, the detent notch 154 may also be positioned anywhere along the boundary providing for a continuously variable resistance window opening 128 .
  • the slide control 126 as shown in FIGS. 15 , 16 and 17 has located therein a port 143 .
  • the port 143 may be of any size or shape and in the illustrated embodiment is generally a rounded triangle having an elongated point.
  • the port 143 operates in conjunction with the resistance window 128 .
  • the size of the opening through which the exhalant passes is determined by how much of the port 143 is left uncovered or open and aligned with the resistance window 128 .
  • the slide control 126 is provided with a closure area 145 , as shown in FIG. 16 . Further, the slide control 126 is provided additionally with a port area 160 .
  • the closure area 145 of the slide control 126 is congruent with or aligned with the resistance window 128 .
  • the port area 160 containing the port 143 is brought into alignment with the resistance window 128 in the mouthpiece 116 .
  • a continuously variable opening is provided. For example, as the slide control 126 moves aligning a greater and greater amount of the port 143 with the resistance window 128 , a greater opening or path for the exhalant is provided.
  • the slide control 126 is seated in a channel 150 located on the mouthpiece 116 .
  • the slide control 126 is slidably movable within the channel 150 in the manner described above so as to continuously variably align the port 160 with the resistance window 128 .
  • a retaining ridge 162 fits into the channel 150 thereby holding the slide control 126 in its desired position throughout its range of motion in the mouthpiece.
  • the desired position of the slide control 126 is as close as possible to the annular sealing ring 164 shown in FIG. 13 .
  • the annular sealing ring 164 may optionally be provided with at least one locating ring or post 166 to help maintain the slide control 126 in alignment.
  • a patient's exhalation effort is controlled by adjusting the slide control over the resistance window so that the patient's exhaled air, which is prevented from entering the aerosol chamber 114 by the annular valve 124 and a baffle (not shown), must exit through the resistance window and provide a desired exhalation resistance. More specifically, during inhalation the inner diameter 127 of the annular valve 124 ( FIG.
  • the exhalation flange 186 of the valve 124 flexes to seal against the outer ridge 188 ( FIG. 13 ) formed inside the mouthpiece 116 to prevent ambient air from entering the mouthpiece.
  • the process is reversed and the inner diameter 127 prevents exhalant from entering the aerosol holding chamber while the exhalation flange 186 flexes away from the outer ridge 188 .
  • the exhalant preferably passes through the resistance window 128 and may escape to the outside between the exhalation flange and the mouthpiece, and then through the gap between the mouthpiece and aerosol holding chamber.
  • the aerosol delivery apparatus includes a chamber housing 214 having an input end 220 and an output end 222 .
  • the chamber housing 214 , input end 220 , and output end 222 define an interior space 223 .
  • the apparatus may also include an elastomeric backpiece which may be similar to the backpiece in the embodiment shown in FIGS. 1-3 .
  • the output end 222 of the chamber housing 214 is shaped to receive the mouthpiece 216 and includes locking tabs 281 and a protrusion 283 .
  • the protrusion 283 is preferably annular in shape.
  • the locking tabs 281 are spaced apart around the outside of the output end 222 .
  • the mouthpiece assembly 216 is preferably substantially similar to that illustrated in FIGS. 10-15 .
  • the mouthpiece assembly includes an annular sealing ring 224 , and a resistance window defined by a gap 225 in the sealing ring.
  • a slide control 226 is slidably seated in a channel 250 between the annular sealing ring and support posts or a support ring.
  • the tab setting 246 protrudes from the tab window 248 in the mouthpiece 216 .
  • the continuously variable resistance function is achieved as described above, using either embodiment of slide control and nozzle described above.
  • a containment baffle 275 may be integrally formed with the chamber housing 214 from a single piece of material and located near the outlet end 222 .
  • the containment baffle 275 includes connecting members 276 that extend from the edge of the containment baffle to the inner diameter of the output end 222 in the chamber housing. Vents 277 are defined between the outer perimeter of the containment baffle and the inner diameter of the outlet end of the chamber housing and are separated by the connecting members.
  • vents 277 are arcuate in shape and conform to the outer perimeter of the containment baffle 275 .
  • the containment baffle is dome-shaped where the concave end points towards the chamber 223 .
  • the containment baffle may be any of a number of geometric shapes.
  • a valve 278 having a valve member 279 and a valve seat 280 is shown.
  • the valve seat 280 preferably comprises the rim of the valve and the corresponding raised lip 283 on the outlet end 222 of the chamber housing 214 .
  • the valve member has a sealing surface that preferably forms between two parallel portions, or lips, of the valve.
  • the valve material seals against itself when fluid flows against a predetermined flow direction of the valve.
  • the valve is a duck-bill valve where the valve seat 280 is positioned axially away from the valve opening.
  • the valve 278 defines a central open area toward the end having the valve seat.
  • the valve member 279 shown as parallel sealing lips in FIGS.
  • valve seat 280 also provides a seal against the chamber housing 214 during exhalation so that exhalant from a patient must be directed through the continuously variable resistance window in the mouthpiece.
  • the duck-bill valve 278 has a central open area 274 at its base that has a diameter of approximately 26.09 millimeters (mm).
  • the width of the lips that form the valve member 279 is approximately 21.35 mm and the angle at which the walls 285 converge is approximately 72 degrees.
  • the height of the duck-bill valve 278 measured from the upper portion 282 of the valve seat to the valve member 279 is approximately 18.8 mm.
  • the mouthpiece 216 for containing this valve 278 preferably includes a resistance widow gap 225 having a length of 59 degrees of arcuate cut in the annular sealing ring 224 , where the annular sealing ring is approximately 31.4 mm in diameter and has a height of 4.5 mm.
  • valve is adjacent to the output end of the chamber housing.
  • annular valve embodiment of FIGS. 1-3 and 10 - 17 the inner portion of the valve covers the vents at the outlet end of the chamber housing.
  • duck-bill embodiment of FIGS. 18-21 the entire outlet end is covered by the valve.
  • the mouthpiece and outlet end of the chamber housing traps the valve in place. Inhalation by the patient causes the sealing portion of the annular valve to move, or alternatively the lips of the duckbill valve to separate, and permit fluid to pass. Fluid from the chamber housing may be inhaled into the patient's respiratory system through the mouthpiece. The patient may then exhale into the mouthpiece.
  • Exhalation by the patient results in air traveling through the mouthpiece in a direction opposite the predetermined inhalation flow path of the valve.
  • This air which is blocked from passage through the valve along the inhalation path, then passes along a second path through the resistance window in the mouthpiece.
  • the force of the exhaled air causes the outer portion of the valve to move away from the mouthpiece in a direction towards the chamber housing.
  • an exhalation pathway is created between the outer portion of the valve and the mouthpiece through which the exhaled air passes out to the atmosphere or some other predetermined location.
  • the amount of effort that exhalation requires is set by the slide control, which may be set to block the appropriate amount of the resistance window to achieve the desired resistance.
  • the duck-bill valve 278 assists both in preventing inhalation of ambient air through the resistance window 225 and providing an exhalation path for exhalant.
  • the upper portion 282 of the valve seat seals against the annular sealing ring 224 except for the gap in the annular sealing ring 224 defining the resistance window 225 .
  • fluid flows through the central opening 274 and out the lips of the valve member 279 .
  • the exhalation flange 286 flexes toward the proximal end of the mouthpiece and provides a secondary seal against the outer ridge 288 inside the mouthpiece.
  • the outer ridge 288 is preferably continuous around the inner circumference of the mouthpiece. Upon exhalation, the lips of the valve member 279 close, the exhalant passes through the resistance window under the upper portion 282 of the valve seat positioned adjacent the resistance window opening, and the exhalation flange flexes away from the outer ridge 288 and out between the aerosol holding chamber 214 and mouthpiece 216 .
  • an embodiment of an apparatus 310 for performing PEP therapy is disclosed that may be used with or without an aerosol delivery apparatus.
  • the PEP apparatus of FIGS. 22a-22c is a standalone PEP device in a mouthpiece incorporating the previously discussed continuous variable resistance window with slide control, and variations thereof, along with a self contained valve 378 that may be similar to that disclosed in the previous embodiments.
  • the valve 378 need not be found on the outlet end of a separate chamber extension 314 but may be positioned on the distal end 330 of the mouthpiece.
  • the valve 378 may be an annular valve.
  • the 378 is preferably retained toward the distal end 330 of the apparatus by a central baffle 385 supported by radial spokes 386 .
  • the PEP apparatus 310 is formed of an attachable mouthpiece section 316 and a baffle section 317 .
  • the mouthpiece and baffle sections 316 , 317 may be removably joined using snap-fit, threaded or other known attachment schemes.
  • the mouthpiece and baffle sections 316 , 317 may be integrally molded or welded shut to form a non-removable, unitary piece.
  • An extended inlet 314 without any valves, may be used with the stand-alone PEP device 310 to enhance delivery of any medicine to the patient's respiratory system.
  • One function of the extended inlet is to provide a chamber for the dispensed particles from the pressurized metered dose inhaler.
  • a pressurized metered dose inhaler may be coupled to the extended inlet with a backpiece and medicament supplied from the pressurized metered dose inhaler can be delivered directly to the user.
  • FIGS. 1-22 illustrate annular and duck-bill valves 24 , 124 , 278 , 378
  • a preferred valve is capable of passing a fluid moving in a first direction along a first path and also capable of passing a fluid moving in an opposite direction along a second path.
  • inhalation draws fluid through a central opening in the valve while the perimeter of the valve prevents fluid flow.
  • exhalation closes the path through the central opening and directs fluid along a second path around the perimeter of the valve.
  • Other paths may also be used.
  • FIGS. 23-28 illustrate another embodiment of a PEP apparatus 410 .
  • the PEP apparatus 410 has a patient respiratory system interface, such as a mouthpiece 416 , on a proximal end 432 and may be connected with an aerosol delivery apparatus, in this example a nebulizer 414 , at a distal end 430 .
  • the PEP apparatus includes a PP valve 412 positioned on top of the mouthpiece 416 .
  • the PP valve 412 preferably consists of a cover 417 that may be removably attached to a receiving area 419 ( FIG. 24 ) on the mouthpiece 416 .
  • the cover has a resistance window 428 and a tab window 448 extending through a top surface.
  • a slide control 426 in the form of a disk with vents 460 extending through the thickness of the disk is movably positioned under the cover 417 .
  • a one-way valve 423 is positioned between the slide control 426 and the top of the mouthpiece 416 to allow air exhaled into the proximal end 432 to escape through the resistance window 428 while preventing any air from entering through the resistance widow during inhalation.
  • the resistance window 428 is shown generally as a pie-slice shaped cut-out with the point of the pie-slice removed so as to form a concave edge.
  • the resistance window 428 may be any shape and should not be limited by the illustrated embodiment.
  • a plurality of resistance windows 428 may form the PP valve 412 .
  • the number of windows 428 is not intended to be limited by the illustrated embodiment.
  • the slide control 426 is shown as a circular disc having a pie-slice shaped cut-outs with the point of the pie-slice openings therein which correspond to the openings of the resistance window 428 .
  • aligning the openings 460 of the disc with the resistance window 428 controls the opening of the continuously variable resistance window 428 .
  • the resistance windows 428 are aligned with the disc openings 460 , the resistance windows 428 are opened to their fullest extent allowing the resistance of the exhalant exiting the PP valve 412 to be lower.
  • the resistance of the exhalant exiting the PEP apparatus 410 is increased.
  • the vents may be adjusted in the disk 417 to any of a number of positions, thereby providing a continuously adjustable resistance. In this manner, positive expiratory pressure is controlled.
  • nebulizer Upon inhalation, the nebulizer will provide an aerosol to the inhaling patient via the mouthpiece.
  • a suitable nebulizer for use with the PEP apparatus 410 is a breath-actuated nebulizer such as disclosed in U.S. Pat. No. 6,044,841 issued Apr. 4, 2000 and entitled “Breath Actuated Nebulizer with Valve Assembly Having Relief Piston”, the entirety of which is incorporated herein by reference.
  • a piston 452 is drawn down by negative pressure created by the inhalation in the nebulizer and ambient air is drawn through openings 454 in the lid 456 of the nebulizer 414 .
  • the one-way valve 459 in the PP valve assembly 412 remains shut during inhalation.
  • a positive pressure builds in the nebulizer 414 and the piston acts as a one-way valve to close off the flow of air out of the nebulizer.
  • the exhalant must travel through the one-way valve in the PP valve assembly 412 , through the slide control and out the resistance window.
  • the slide control 426 under the resistance window 428 has been set to the appropriate position for the patient so that effective PEP therapy may be provided.
  • the PEP apparatus of FIGS. 23-27 uses an aerosol delivery apparatus such as the nebulizer 414 to restrict air flow through any opening other than the PP valve assembly 412 , other embodiments, such as shown in FIG.
  • FIGS. 23-28 show an improved nebulizer 414 associated with a PEP apparatus 410 having a PP valve 412 .
  • the nebulizer may be used alone or in combination with a mouthpiece mounted PP valve 412 or mask mounted version of the PP valve discussed below.
  • FIG. 29 shows an alternative embodiment of the PEP apparatus 410 of FIGS. 23-28 that may be used alone or coupled to a nebulizer or other aerosol delivery apparatus.
  • the mouthpiece 462 is provided with a one-way inhalation valve assembly 463 having a membrane 464 captured in an outlet cover 465 attached to the distal end 466 of the mouthpiece.
  • the flexible membrane preferably covers vents in the outlet cover 465 during exhalation and flexes to allow fluid flow during inhalation.
  • a PP valve assembly 467 is positioned on top of the mouthpiece. The PP valve assembly 467 differs from the PP valve assembly 412 in FIGS.
  • the slide control 468 contains a circular opening 469 that is moved by the tab setting 469 under a tear-drop shaped resistance window 471 in the cover 472 .
  • the inhalation valve 463 allows for fluid to enter the mouthpiece 462 but prevents fluid from exiting the mouthpiece.
  • the exhalation valve 473 allows for exhalation through the resistance window 471 but prevents inhalation of particles or fluid. When assembled, a gap is present between the exhalation valve 473 and the slide control 468 in order to allow the exhalation valve 473 to open upon exhalation. In this manner, the mouthpiece 462 is adapted to be used alone and not in conjunction with a nebulizer or other aerosol delivery apparatus.
  • FIG. 30 shows one embodiment, similar in concept to the embodiment of FIG. 29 , but with the PP valve 475 attached in series with the one-way inhalation valve 476 , rather than in series with the one-way exhalation valve, to provide for resistance upon inhalation only.
  • the arrows drawn in FIG. 30 depict the direction of travel from the downstream end of the mouthpiece 478 to the upstream end of the mouthpiece showing that all inhalation must pass through the continuous variable resistance window 480 and the port 482 of the slide control 484 .
  • PP valves may be placed in series with both the one-way input and one-way output valves to allow for simultaneous control of positive inspiratory and expiratory pressures at the same or different levels.
  • FIGS. 31-35 A PP apparatus 510 utilizing a mask 512 as the interface is illustrated in FIGS. 31-35 .
  • the mask may be a standard mask sized for adults or children and constructed of any of a number of materials such as silicon rubber.
  • the mask 512 may have a frustoconical shaped main section 514 sized to cover the patient's mouth and a nosepiece section 516 sized to cover a patient's nose.
  • a central opening 518 in the mask 512 may be used to attach with an aerosol delivery apparatus such as the aerosol holding chamber 14 shown in FIGS. 1-3 , and other aerosol delivery apparatus.
  • the mask 512 may be fitted with a one-way valve in the central opening 518 for use as either a positive expiratory pressure device or a positive inspiratory pressure device.
  • a PP valve assembly 520 is positioned on the device so that inspiration and exhalation paths travel off-axis from one another.
  • the PP valve assembly 520 has an adjustable valve assembly cover 534 with tab window 522 and resistance window 528 openings positioned on it.
  • the resistance window 528 is generally an oblong, tear-drop shape and the tab window 522 defines an arcuate opening in the PP valve cover 534 .
  • the tab window and resistance window may alternatively be rectangular, oval or any other shape.
  • the PP valve assembly 520 has a fixed opening 530 and a set of detents 532 positioned on a disk-shaped platform 526 that connects to the nosepiece section of the mask through complementary tab 542 and slot 544 connectors.
  • the PP valve cover 534 has a protrusion 536 sized to cooperate with the detents 532 on the platform 526 so that the valve cover may be moved to predetermined spots when the valve cover is rotated against the platform.
  • An axle 538 on the valve cover fits into a central opening 540 in the platform 526 so that the resistance window 528 is rotatably positionable over the exhalation port 530 and the tab window 522 lines up with the tab extending from the platform 526 .
  • This embodiment depicts the resistance window 528 as a curved tear-drop like shape.
  • the platform 526 is shown as a circular disc having at least one port opening 530 .
  • the port opening 530 may vary in size and shape.
  • the opening formed for the exhalant to pass through is related to the alignment of the resistance window 528 with the port opening 530 .
  • the resistance window is moveably mounted relative to a fixed slide control portion attached to the mask.
  • Tabs 542 on the platform 526 preferably mate with tab receiving regions 544 on the end of the nosepiece section 516 to retain the platform in a fixed position relative to the mask. Moving the tear-drop shaped resistance window 528 past the part opening 530 vanes the exhalant path.
  • a plurality of resistance window openings 528 may be moved past the port 530 .
  • one end of the tear-drop shaped resistance window 528 matches the size of the largest port opening 530 at a maximum flow position thereby providing a maximum flow and least resistance in that position.
  • the valve cover is rotated so that the resistance window 528 covers a greater portion of the port, as shown in FIGS. 33a-33b , a smaller exhalant path is created providing greater resistance.
  • moving the valve cover until the tab reaches the opposite end of the tab window results in the smallest amount of the port being open, the highest airflow resistance and the least flow.
  • FIG. 36 an embodiment is shown of a valve cover 550 having indicia 552 representative of a resistance setting.
  • the indicia 552 are arranged to cooperate with the tab extension 554 on the platform to indicate the current resistance setting.
  • PEP therapy maybe performed with a mouthpiece or mask having the PP valve associated with a backpiece.
  • the mask or mouthpiece may have an extended inlet for association with the backpiece.
  • pressurized metered dose inhalers are generally cylindrical canisters 700, as shown in FIG. 18, with axially extending vent tubes from internal valves.
  • pressurized metered dose inhalers When the external tube or stem of a pressurized metered dose inhaler canister 700 is depressed it operates the internal valve to dispense a measured dose of medicine from the stem.
  • the medicine is commonly packed in the canister with a suitable compressed gas to propel the medicine and gas from the stem or tube when the later is depressed.
  • the medicine may be in gas, liquid, or solid form.
  • the manufacturer or distributor of the pressurized metered dose inhaler canister generally supplies it with a substantially L-shaped adapter 602 which receives the canister in a substantially upright position, and has a substantial horizontal outlet portion for reception in the mouth of an asthmatic patient for inhalation of the medicine.
  • a spacer chamber with an integrated actuator, or an aerosol holding chamber have been used in attempts to overcome inappropriate particle size.
  • the aerosol holding chamber is generally provided at the upstream or entering end with a flexible, resilient adapter or backpiece made of rubber or the like material.
  • a central aperture is provided for receipt of the horizontal outlet portion of the pressurized metered dose inhaler adapter.
  • a PP apparatus 600 may be associated with the pressurized metered dose inhaler or the pressurized metered dose inhaler with an aerosol holding chamber.
  • an L-shaped adapter portion 602 holds the pressurized canister and a horizontal outlet section 604 receives the medicament released in aerosol form.
  • a one-way valve 606 which may be a flexible membrane, a rigid membrane, hinged door, or other commonly known valve mechanism is positioned at the proximal end 608 of the horizontal outlet section 604 .
  • the one-way valve 606 permits inhalation and blocks exhalation so that substantially all exhalation is routed through the variable resistance window 610 adjacent the one-way valve 606 .
  • a slide control 612 is movable in the resistance window 610 by a tab 614 to close off or open up as much of the resistance window as necessary to provide the desired expiratory pressure.
  • FIGS. 38a and 39a illustrate the slide control in a completely open position and FIGS. 38b and 39b illustrate the slide control closing off the resistance window.
  • the slide control may maintain its position in the resistance window through friction, detents or other known mechanisms for mechanically retaining one of multiple desired positions.
  • FIG. 40 illustrates another embodiment of a pressurized metered does inhaler 620 with a round proximal end 628 that may be used without the need for special mouthpieces or aerosol holding chambers.
  • the alternative PEP enabled pressurized metered dose inhaler 620 has a one-way valve 626 that shunts exhalant through a resistance window 622 that is continuously adjustable with a slide control 624 that can adjust the aperture of the resistance window.
  • a mouthpiece or mask may be associated the PP apparatus.
  • an aerosol holding chamber may be attached to the mouthpiece or mask end and a metered dose inhaler may be positioned on a generally opposite end of the chamber via a backpiece.
  • the user of the device may insert the mouthpiece into the mouth to obtain a dose of medicament. Further, the user may place the mask over the mouth and/or nose to inspire a dose of the medicament. In either situation, the mask or mouthpiece aids in the delivery of the medicament to the user.
  • a method and apparatus from providing positive expiration or inhalation therapy, with or without separate aerosol generating devices has been disclosed.
  • the positive expiratory pressure valve is located at or near the output end of the aerosol delivery apparatus
  • a one way inhalation valve can be located further downstream from the positive expiratory pressure valve.
  • a mouthpiece and or mask can be affixed at or near the output end of the aerosol delivery apparatus.
  • the positioning of the inhalation valve either upstream or downstream in respect to the positive expiratory pressure valve is well known to one skilled in the art. Further, it is envisioned that PEP therapy may be performed nasally with the positive expiratory pressure apparatus.
  • a one way inhalation valve is engageable with the mouthpiece.
  • the inhalation valve functions so as to allow for inhalation by the patient into the mouthpiece.
  • the exhalant of the patient is prevented from exiting via the inhalation valve and is directed to exit through the PP valve.
  • an inhalation valve opens upon inhalation to allow a fluid, such as an aerosol, to enter a chamber or channel or the like but that closes upon exhalation to prevent exhaled fluids to enter into the chamber of the like.
  • the drawings depict an exemplary embodiment of the one-way inhalation valve but are not to be limiting to the embodiments shown.
  • a physician may initially determine the proper resistance setting of the PP apparatus according to the patient's requirements.
  • One manner in which the PP apparatus may be properly set is by attaching a fitting 39 to the mouthpiece.
  • a manometer is then attached to the fitting port 41 and serves to measure the expiratory pressure.
  • a patient will exhale into the mouthpiece and the pressure can be read from the manometer.
  • the physician can the move the tab to one of the desired settings indicated on the mouthpiece.
  • the fitting 39 can be removed from the mouthpiece. This fitting 39 will not be used again unless it is determined that the resistance should be adjusted.
  • the method of performing PEP therapy using the PP apparatus includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a medicament may be provided for inhalation into the respiratory system. In one embodiment of PEP therapy, the user will exhale into the mouthpiece and/or mask, against the desired resistance. This is done either prior to or in combination with inhalation of the medicament. The exhaled gases exit through the resistance window. This process may be repeated as many times as prescribed by the patient's physician.
  • the aerosol delivery apparatus with the PP apparatus may be used alone or in combination with a mask or mouthpiece. Also, an improved aerosol delivery apparatus with an integrated actuator has been shown, wherein the improvement comprises a PP valve.
  • the discussion above is descriptive, illustrative and exemplary and is not to be taken as limiting the scope defined by any appended claims.

Abstract

An apparatus and method for performing positive pressure (PP) therapy alone or in combination with an aerosol delivery apparatus. The positive pressure apparatus includes a positive pressure valve having a continuously variable respiratory window. The PP valve may be associated with a patient respiratory system interface alone, such as, but not limited to, a mask or mouthpiece, or in combination with an aerosol delivery apparatus.

Description

Notice: More than one reissue application has been filed for the reissue of U.S. Pat. No. 6,848,443. The reissue applications are Ser. Nos. 11/655,039 (now U.S. Pat. No. Re. 43,174) and 13/371,787.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation reissue of U.S. application Ser. No. 11/655,039, filed Jan. 18, 2007, now Reissue U.S. Pat. No. Re. 43,174, which application is a reissue of U.S. application Ser. No. 10/389,257, filed Mar. 14, 2003, now U.S. Pat. No. 6,848,443, which is a continuation of U.S. application Ser. No. 09/833,019, filed Apr. 11, 2001, now U.S. Pat. No. 6,557,549, which claims the benefit of U.S. Provisional Application No. 60/196,555, filed Apr. 11, 2000, wherein the entirety of each of the aforementioned applications are incorporated herein by reference.
FIELD OF THE INVENTION
The invention relates to an apparatus and method for performing Positive Expiratory Pressure (PEP) therapy. More particularly, this invention relates to a method and apparatus for performing PEP therapy alone or in conjunction with an aerosol delivery apparatus.
BACKGROUND
PEP therapy is used primarily in pulmonary secretion removal. Devices used to perform PEP therapy provide positive pressure during expiration. The patient or user exhales against a fixed orifice resistor and generates a pressure ranging approximately from 10-20 cm H2O. The resistance orifice is an important consideration and frequently is initially set by a physician, veterinarian, or a skilled practitioner in the art. An orifice that is too large may result in a short exhalation that will not produce proper expiratory pressure. An orifice that is too small may result in a longer expiratory phase that raises the pressure above approximately 20 cm H2O and ultimately increases the work of breathing.
During the exhalation phase of PEP therapy, the airway is splinted open by the pressure. This causes the movement of secretions from the peripheral airways into the larger airways where they can be expelled. PEP therapy usually lasts for about 10-20 minutes and is performed as required, generally 1-4 times per day. Typically, the patient performs 10-20 PEP breaths, removes the device from their mouth and follows this with a forceful exhalation. This final exhalation triggers a cough that loosens secretions.
Studies indicate that PEP therapy dilates the airways and improves the distribution of ventilation, resulting in a better deposition of an inhaled substance, such as, but not limited to, a medicine or remedy. As used herein, the term “aerosol delivery apparatus” means any apparatus capable of producing and/or delivering a substance, such as, but not limited to, a medicine, in a form suitable for inhalation by a patient and includes, without limitation, an aerosol holding chamber, nebulizer, spacer with integrated actuator, a dry powder inhaler, and a metered dose inhaler.
SUMMARY OF THE INVENTION
One aspect of the present invention is directed to a positive respiratory pressure apparatus including a patient respiratory system interface and a valve assembly in fluid communication with the patient respiratory system interface. The valve assembly has a valve configured to pass a fluid traveling in a predetermined direction from a first side to a second side of the valve, and a variable resistance bypass window positioned adjacent the valve and having a resistance to a fluid traveling in a direction opposed to the predetermined direction, where the variable resistance bypass window is continuously adjustable between a first fluid resistance and a second fluid resistance.
According to another aspect of the invention an apparatus is disclosed that is capable of performing positive expiratory pressure (PEP) therapy alone or in combination with providing a substance, generally in aerosol form. The apparatus includes a positive pressure (PP) valve having a continuously variable respiratory window. As used herein, the term respiratory is intended to encompass both inhalation and exhalation. Whether inhalation resistance or exhalation resistance is called for will be known to one skilled in the art. The valve may be located at or near the output end of an aerosol delivery apparatus. U.S. application Ser. No. 08/938,686 filed Sep. 26, 1997 in the name of Engelbreth et al. and Ser. No. 09/287,997 filed on Apr. 7, 1999 in the name of Schmidt et al. describe exemplary embodiments of an aerosol delivery apparatus and the disclosures of these references are incorporated herein by reference. Further, U.S. Pat. No. 4,470,412 to Nowacki et al., describing a spacer or expansion chamber, is additionally incorporated herein by reference. The aerosol delivery apparatus with the PP apparatus may be used alone or in combination with a mask or mouthpiece.
In one embodiment, the PP apparatus is associated with a mask. The mask with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus. In another embodiment, the PP apparatus is associated with a mouthpiece. The mouthpiece with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus. In a further embodiment, the PP apparatus is associated with a nebulizer. The nebulizer with the PP apparatus may be used alone or in combination with a patient respiratory system interface, such as a mask or mouthpiece. In yet another embodiment, the PP apparatus is associated with a spacer chamber with an integrated actuator. The spacer chamber with the integrated actuator associated with the PP apparatus may be used alone or in combination with a mouthpiece or mask.
In another embodiment, a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber having a PP valve associated therewith. In yet a further embodiment, a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber engageable with a mouthpiece or mask having a PP valve associated therewith.
Another aspect of the invention is directed to a kit for performing positive expiratory pressure including an aerosol delivery apparatus, a mouthpiece and/or mask attachable to the output end of the aerosol delivery apparatus, and a PP apparatus. The PP apparatus may be located on the aerosol delivery apparatus or the mouthpiece and/or mask. In alternative embodiments, the PP apparatus may be attached to the aerosol delivery apparatus or integrally formed with the apparatus. The aerosol delivery apparatus, mouthpiece, and PP valve can be combined so as to accomplish positive expiratory therapy and administration of a substance, such as, but not limited to, a medicine in aerosol form. Any aerosol delivery apparatus may be used. In further embodiments of the kit, a backpiece is included for association with an aerosol delivery apparatus. A pressurized metered dose inhaler can engage with the backpiece for delivery of a medicament.
One embodiment of a method of performing positive expiratory pressure therapy includes providing a PP apparatus with a valve that is capable of providing a continuously variable expiratory window. The method further includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a substance, such as a medicament, may be provided for inhalation into the respiratory system. In an alternative embodiment of method, the PP valve may be positioned so as to provide positive inspiratory pressure upon inhalation into the apparatus.
A further aspect of another embodiment includes association of a PP apparatus associable with a mask or mouthpiece engageable with a backpiece device. The backpiece device includes a plastic or an elastomeric adapter suited to receive the mouthpiece of a pressurized metered dose inhaler.
One embodiment of a method of performing positive expiratory pressure therapy includes providing a positive expiratory pressure apparatus having a valve capable of providing a continuously variable resistance window, performing a series of breaths including inhalation and exhalation; exhaling so that the exhalant is directed through the continuously variable resistance window, performing a therapeutic cough triggering the loosening of secretions, and providing an inhaleable medicament.
Another embodiment of a method of performing positive expiratory pressure therapy includes providing a positive respiratory pressure apparatus having a valve capable of providing a continuously adjustable resistance to exhalation, where the valve is located in a mouthpiece attachable to a chamber. A patient then executes a series of therapeutic breaths, including inhalation and exhalation, wherein the exhalant is directed through the continuously adjustable resistance window, the patient performs a therapeutic cough triggering the loosening of secretions, and medicament is provided via the chamber.
According to another aspect of the invention, a method of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes providing a positive expiratory pressure apparatus having a positive expiratory pressure valve capable of providing a continuously variable resistance window, where the valve is positionable in a mouthpiece and the mouthpiece attachable to an aerosol holding chamber. A series of therapeutic breaths, including inhalation and exhalation, are then taken where the exhalant is directed through the continuously variable resistance window. The continuously variable resistance window is preferably capable of providing a variable back pressure to the exhalant. A therapeutic cough capable of triggering the loosening of sections is performed and aerosolized medicament from the aerosol holding chamber is administered through inhalation.
One embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; and an aerosol holding chamber having an output end, the positive respiratory pressure valve locatable at the output end.
Another embodiment of an apparatus capable of performing positive respiratory pressure therapy includes a positive respiratory pressure valve having a slide control, the slide control providing a continuously variable resistance window; and a mouthpiece, the mouthpiece having a first and a second end, the second end capable of association with the positive respiratory pressure valve.
Yet another embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; an aerosol holding chamber having an input end and an output end, the positive respiratory pressure valve locatable at the output end; and a metered dose inhaler canister capable of association with the input end of the aerosol holding chamber.
A still further embodiment of a kit for performing positive expiratory pressure includes an aerosol holding chamber having an inlet and an outlet. A backpiece is attachable to the inlet of the aerosol holding chamber with a metered dose inhaler capable of association with the backpiece. A mouthpiece is attachable to the outlet of the aerosol holding chamber. A positive expiratory pressure valve is generally locatable at the outlet end of the aerosol holding chamber, wherein the aerosol holding chamber, backpiece, mouthpiece, and positive expiratory pressure valve can be combined so as to accomplish positive expiratory therapy and administration of an aerosolized medicament.
An additional embodiment of an apparatus capable of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes a positive expiratory pressure valve having a continuously variable resistance window, a mouthpiece, the positive expiratory pressure valve associable with the mouthpiece, and a nebulizer having an input end and an output end, the positive expiratory pressure valve associable with the output end.
Further embodiments include a mouthpiece wherein the improvement comprises a positive pressure valve. An additional embodiment includes a nebulizer wherein the improvement comprises a positive pressure valve. Moreover, an embodiment includes an aerosol holding chamber wherein the improvement comprises a positive pressure valve. A yet further embodiment includes a pressurized metered dose inhaler wherein the improvement comprises a positive pressure valve.
The invention will best be understood by reference to the following detailed description of the preferred embodiment, taken in conjunction with the accompanying drawings. The discussion below is descriptive, illustrative and exemplary and is not to be taken as limiting the scope defined by any appended claims.
BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGS
FIG. 1 is a cross sectional view of a mouthpiece associable with a chamber in conjunction with a PP apparatus.
FIG. 2 is a perspective view of a mouthpiece associable with a chamber in conjunction with the PP apparatus.
FIG. 3 is an exploded view of the preferred embodiment.
FIG. 4a is a front view of one embodiment of the PP apparatus.
FIG. 4b is a cross section drawn along line A-A of FIG. 4a.
FIG. 4c is a back view of one embodiment of the PP apparatus.
FIG. 4d is a cross section drawn along line B-B of FIG. 4a.
FIG. 4e is a sectional cross section drawn along line C-C of FIG. 4a.
FIG. 4f is a rear perspective view of the embodiment of FIG. 4a.
FIG. 5 is a rear perspective of a mouthpiece according to a preferred embodiment.
FIG. 6 is a front perspective view of a mouthpiece with one embodiment of the PP apparatus.
FIG. 7a is a front view of the fitting and manometer port.
FIG. 7b is a cross section drawn along line A-A of FIG. 7a of the fitting and port.
FIG. 8a is a top view of one embodiment of the slide control.
FIG. 8b is a side view of one embodiment of the slide control.
FIG. 8c is a perspective view of one embodiment of the slide control.
FIG. 8d is a cross section drawn along line A-A of FIG. 8a.
FIG. 9 is a top perspective view of one embodiment of the slide control.
FIG. 10 is a perspective view of an alternative embodiment of the PP apparatus of FIGS. 1-3 showing detent notches in conjunction with a mouthpiece.
FIG. 11 is an exploded view of one embodiment showing a slide control having a port.
FIG. 12 is one embodiment of the slide control having a port.
FIG. 13 is one embodiment of the mouthpiece showing the annular sealing ring.
FIG. 14 is one embodiment showing a plurality of detent notches.
FIG. 15 is a side view of one embodiment of the control valve showing the port.
FIG. 16 is a concave perspective view of the slide control showing the port.
FIG. 17 is a concave bottom view of the slide control showing the port.
FIG. 18 is an exploded view of an alternative embodiment of the PP apparatus of FIGS. 8-10.
FIG. 19 is a cross-sectional view of the PP apparatus of FIG. 18.
FIG. 20 is a perspective view of a duck-bill valve used in the PP apparatus of FIGS. 18-19.
FIG. 21 is a cross-sectional view of the duck-bill valve of FIG. 20.
FIG. 22a is a front exploded view of one embodiment of the PP apparatus in conjunction with a mouthpiece and associable with a spacer.
FIG. 22b is a rear exploded view of one embodiment of the PP apparatus in conjunction with a mouthpiece and associable with a spacer.
FIG. 22c is a front view of one embodiment of a valve showing the baffle.
FIG. 23 is a perspective view of one embodiment of a PP apparatus in association with a nebulizer.
FIG. 24 is an exploded view of one embodiment of the PP apparatus and a mouthpiece.
FIG. 25 is a perspective view of one embodiment of the PP apparatus in an open position and a mouthpiece.
FIG. 26 is a perspective view of one embodiment of the PP apparatus in a semi-open position and a mouthpiece.
FIG. 27 is an exploded view of one embodiment of the PP apparatus showing the disc and a mouthpiece.
FIG. 28a is a top view of one embodiment of the PP apparatus and a mouthpiece.
FIG. 28b is a cross section of one embodiment of the PP apparatus and a mouthpiece showing a plurality of prongs holding the PP apparatus.
FIG. 29 is an exploded view of a PP apparatus associated with a mouthpiece and having an inhalation valve.
FIG. 30 is an exploded view of a PP apparatus associated with a mouthpiece and having an exhalation valve.
FIG. 31 is a further perspective view of one embodiment of the PP apparatus in conjunction with a mask having an opening for association with a chamber.
FIG. 32a is a close up of one embodiment of the PP apparatus in a fully open position in conjunction with a mask.
FIG. 32b is a cross section of one embodiment of the PP apparatus in a fully open position in conjunction with a mask.
FIG. 33a is a close up of one embodiment of the PP apparatus in a partially open position in conjunction with a mask.
FIG. 33b is a cross section of one embodiment of the PP apparatus in a partially open position in conjunction with a mask.
FIG. 34a is a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
FIG. 34b is a cross section of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
FIG. 35a is a front exploded view of a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
FIG. 35b is a rear exploded view of a close up of one embodiment of the PP apparatus having a plurality of variable sized flow ports, in conjunction with a mask.
FIG. 36 is a front view of one embodiment of the PP apparatus showing resistance setting indicia.
FIG. 37 shows a perspective view of a spacer for a pressurized metered dose inhaler with one embodiment of the PP apparatus.
FIG. 38a is a perspective view of one embodiment of the resistance window in the open position.
FIG. 38b is a perspective view of the embodiment of FIG. 38a with the resistance window in a closed position.
FIG. 39a is a perspective view of one embodiment of the resistance window in the open position.
FIG. 39b is a perspective view of one embodiment of the resistance window in the closed position.
FIG. 40 illustrates an alternative embodiment of the apparatus of FIGS. 37-39.
DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
FIGS. 1-3 show one embodiment of an assembly 10 for performing positive expiratory pressure (PEP) therapy where the assembly incorporates a positive pressure (PP) device having a PP valve 12. The assembly 10 includes an aerosol delivery apparatus, such as an aerosol holding chamber 14, and a patient respiratory system interface, such as a mouthpiece 16 and/or mask attachable to the output end of the aerosol delivery apparatus. The PP valve 12 may be located on the aerosol delivery apparatus or the patient respiratory system interface. The assembly 10 combines the aerosol delivery apparatus, mouthpiece, and PP valve into a tool for use in both positive expiratory therapy and administration of a substance, such as a medicament, in aerosol form. Any aerosol delivery apparatus suitable for generating an aerosol of the desired substance may be used.
In the embodiment of FIGS. 1-3, a backpiece 18 is attachable to the inlet 20 of the aerosol holding chamber 14. A metered dose inhaler (not shown) may be connected with the backpiece 18. The mouthpiece 16 is attachable to the outlet end 22 of the aerosol holding chamber 14. The PP valve 12 is generally locatable at the outlet end 22 of the aerosol holding chamber 14. FIG. 3 depicts an exploded view of the PEP assembly showing an annular valve 24 positioned between the outlet end 22 and the mouthpiece 16. More details on the aerosol holding chamber 14 disclosed in FIGS. 1-3 may be found in U.S. Pat. No. 4,470,412 and U.S. patent application Ser. No. 09/287,997 incorporated above.
In the embodiment depicted in FIGS. 1 and 2, the aerosol holding chamber 14 is provided with an annular valve 24 located at its outlet end 22. The annular valve 24 allows the user to inhale medicament from the chamber 14, but prevents exhalation back through the chamber. As illustrated in FIGS. 1-3, and in more detail in FIGS. 4a-4f, 5 and 6, a PP valve 12 may be formed in a mouthpiece 16. The PP valve 12 includes a slide control 26 that is movably positioned relative to a resistance window 28. The slide control 26 is variably maneuverable to cover or uncover the resistance window 28 in a continuous manner. Further, the movement of the slide control 26 includes, but is not limited to, covering or uncovering, and/or opening or closing, the resistance window 28 or any variations thereof.
The PP valve 12 may be located on or in conjunction with a mouthpiece 16. An exemplary embodiment of the mouthpiece 16 shown in FIGS. 4a-4f has a distal end 30 and a proximal end 32. Commonly, the proximal end 32 of the mouthpiece is inserted or associated with the mouth or nostrils of the user. Additionally, the distal end 30 of a mouthpiece may or may not be associated with an aerosol delivery apparatus and the mouthpiece alone may be configured to constitute a PEP device.
Generally, in one exemplary embodiment, the PP valve 12 may be located at or near the distal end 30 of the mouthpiece 16. Although, it is understood that the PP valve 12 may be located anywhere on the mouthpiece 1 and its location is not to be limited. In an alternative embodiment, the PP valve 12 may be located at or near the output end 20 of the aerosol delivery apparatus, such as, but not limited to, the aerosol holding chamber 14 of FIGS. 1-3. Generally, the direction of travel of any fluid, particularly an aerosol or nebulizer medicament, is in the direction from the input end 20, through the channel or chamber body, and to or out the output end 22. This direction of travel from input end 20 to output end 22 is referred to as travel from downstream to upstream.
In a preferred embodiment the mouthpiece 16 is formed of plastic. The plastic may be either rigid or soft. Other materials that can also be used for the mouthpiece 16 include metal or other materials known to one in the art. In the embodiment depicted in FIGS. 1-3, 4a, 4b, 4c, and 4f, a tab 34 is provided allowing for the connection of a cap 36, as shown in FIG. 2, to cover the proximal end 32 of the mouthpiece 16. In a preferred embodiment, the mouthpiece 16 may include indicia 35, or setting indications, representing the resistance setting. The indicia 35 may be in the form of numbers, bars, colors, a series of dots or the like.
In a further embodiment, as shown in FIGS. 7a and 7b, the PP apparatus 10 may includes a fitting 39 sized for placement over the proximal end of the mouthpiece. The fitting 39 includes a manometer port 41 extending from the fitting over which a manometer can be attached. In a preferred embodiment the fitting 39 is formed of a plastic. The plastic may be either rigid or soft. Other materials that can also be used to form the fitting include metal.
FIGS. 3, 8a-8d and 9 show an embodiment of the slide control 26 of the PP apparatus 10. As shown in FIG. 9, in the illustrated embodiment, the slide control 26 is of a semi-circular, quarter moon shape. The slide control 26 has a first lateral side 38 concave in shape and a second lateral side 40 opposite the first side 38. The slide control 26 also has a top 42 and a bottom 44 surface. From the top surface 42 of the slide control 26 extends a tab setting 46.
In the illustrated embodiment, the tab setting 46 is a uniformly molded projection from the slide control 26. In a preferred embodiment, the tab setting 46 has smooth edges for easy engagement with the finger, thumb or appendix of the user. The tab setting 46 may also have a serrated edge or any other edge known in the art. When assembled with the mouthpiece 16, the tab setting 46 projects through the mouthpiece from the tab window 48. The user of the device manipulates the tab setting 46 in such a manner as to cause, either directly or indirectly, the movement of the slide control 26 thereby varying the opening of the resistance window 28.
In the embodiment of FIGS. 1-3, 4a-4f, 5 and 6, the tab window 48 is arcuate in shape, parallel to the contour of the circumference of the mouthpiece 16. Referring to FIG. 4f, the slide control 26 is preferably seated in a channel 50 located on the mouthpiece 16. The slide control 26 is held within the channel 50 by at least one tooth 52. Located on one or both of the walls of the channel 50 is a stepped surface 54 as shown in FIG. 5.
In the embodiment shown in FIGS. 8a and 6, the control arm 56 of the slide control 26 is shown having a finger protection 58 from one end of the slide control 26. In another embodiment, the slide control 26 may have a control arm 56 located on both ends of the slide control 26. The finger projection 58 is capable of engagement with the stepped surface 54 inside the mouthpiece shown in FIGS. 4c and 5. In the illustrated embodiment, the stepped surface 54 includes a series of ribs extending a variable length of the internal diameter of the mouthpiece 16. In another embodiment, as shown in FIG. 30, the stepped surface 54 may also be located along the tab window 48. Therefore, the location of the stepped surface 54 may vary while remaining engageable by the control arm 56. Additionally, the stepped surface 54 may be located on either or both of the internal walls of the channel 46. In the embodiment of FIGS. 4a-4f and 8a-8d, the slide control 26 is of a flexible material so that the control arm 56 can slide across the uppermost surface of the ribs projecting from the stepped surface 54. When the desired opening of the resistance window 28 is obtained, the control arm 56 engages in a semi-locked manner the ribs projecting from the stepped surface 54.
The end of the slide control 26 opposite the control arm 56 may either be provided with a finger projection 58 or may be smooth. The length of the slide control 26 extending from the tab setting 46 to the end of the control arm 56 opposite the projection 58 is generally the length of the resistance window 28. This resistance control length 60 is at least the length that the resistance window 28 can be opened allowing for exhalant to exit the window 28. In a preferred embodiment, the slide control 26 is manufactured of a plastic. The plastic may be either rigid or soft. Other materials that can also be used for the slide control 26 include metal or other materials known in the art.
In general, as shown in FIG. 5, the resistance window 28 may be an opening of any size or shape in the walls defining the channel 46 in the mouthpiece 16 which, in conjunction with the illustrated embodiment of the slide control 26, provides an opening in the mouthpiece 16 to produce sufficient pressure during exhalation of the patient performing PEP therapy. For example, the resistance window 28 may be formed with straight or slanted edges. If the edges are slanted, this provides a steeped effect to the resistance window 28. If the desired exhalation pressure is determined to range from 10-20 cm H2O, then the resistance window 28 in conjunction with the slide control 26, acting as a cover or closure mechanism for the resistance window 28, are sized in such a manner as to provide an appropriate opening for the desired exhalation pressure to be produced. As one example, if the resistance window 28 is generally narrow, then the length of the window may be of a longer length so as to provide a large enough opening through which PEP therapy is performed. Interdependent in the relationship is the resistance window length 60 of the control arm 26. In the above example, the resistance window length 60 of the control arm 26 is generally longer to cover the desired amount of the resistance window 28. The control arm 26 may provide a continuously adjustable variable resistance window between a first position where the control arm completely blocks the window 28, to a second position where the control arm leaves the window completely open.
An alternative embodiment of an assembly 100 for performing PEP therapy is shown in FIGS. 10-17. This embodiment is similar to the embodiment of FIGS. 11-13, but utilizes a variation of the resistance window and slide control in the PP valve 112. In the assembly 100 of FIGS. 10-17, the resistance window 128 and slide control 126 are positioned in the mouthpiece 116. The tab setting 146 of the slide control 126 is of a flexible material. A detent 158 protrudes from the first tab setting face 156 located on the concave side 125 of the slide control 126. As shown in FIG. 15, a position indicating rib 159 is located on the tab setting 146 opposite the detent 158. In the illustrated embodiment, the rib 159 is shown as a generally rectangular protrusion from the surface of the tab setting 146. Yet, the rib 159 may be any shape protrusion, such as but not limited to circular, triangular. Further, the rib 159 may not be a protrusion at all but rather is a concave marking on the surface of the tab setting 146. The rib 159 has at least the function of indicating to the user the extent of the opening of the resistance window 128. Therefore, one skilled in the art can envision a variety of marking, shapes, indents or protrusions, or colors which serve at least the function of indicating the extent of the opening of the resistance window 28.
The detent 158 located on the tab setting 146 is associated with at least one detent notch 154 as shown in FIGS. 10 and 14. The flexible tab setting 146 is movable within the tab window 148. The one or more detent notches 154 are preferably located along the boundary of the tab window 148 and indicia 135, representative of exhalation effort corresponding to the position of the slide control 126, are arranged adjacent the respective detent positions. FIGS. 10 and 14 show a plurality of detent notches 154. In operation, the flexible tab setting 146 is moved along the tab window 148. The detent 154 located on the first tab fitting face 125 of the tab setting 146 moves into and out of engagement with the detent notches 154. Movement along the boundary and engagement with the detent notches 154 removably fixes the slide control 126 in a variety of positions. Each varied position provides for a further opening or closing of the resistance window 128. Further, in operation, the detent 158 is not limited to being engaged with a detent notch but may be engaged or seated at any point along the boundary. Engagement with, or seating within, a detent notch 154 of a detent 158 provides for a variable securely fixed opening of the resistance window 128. Each detent notch 154 may correspond to a particular size opening or pre-set opening of the resistance window 128. Therefore, by engagement of the detent 158 within the detent notch 154, the user may be provided with a preset resistance window opening 128. Yet, the detent notch 154 may also be positioned anywhere along the boundary providing for a continuously variable resistance window opening 128.
The slide control 126, as shown in FIGS. 15, 16 and 17 has located therein a port 143. The port 143 may be of any size or shape and in the illustrated embodiment is generally a rounded triangle having an elongated point. The port 143 operates in conjunction with the resistance window 128. In the embodiment illustrated in FIGS. 10-17, the size of the opening through which the exhalant passes is determined by how much of the port 143 is left uncovered or open and aligned with the resistance window 128. The slide control 126 is provided with a closure area 145, as shown in FIG. 16. Further, the slide control 126 is provided additionally with a port area 160. When the resistance window 128 is closed or not open and thereby not allowing for the exiting of any exhalant, the closure area 145 of the slide control 126 is congruent with or aligned with the resistance window 128. As the slide control 126 is gradually moved, the port area 160 containing the port 143 is brought into alignment with the resistance window 128 in the mouthpiece 116. In this manner, a continuously variable opening is provided. For example, as the slide control 126 moves aligning a greater and greater amount of the port 143 with the resistance window 128, a greater opening or path for the exhalant is provided.
As described above, and similar to the embodiment of FIGS. 1-3, the slide control 126 is seated in a channel 150 located on the mouthpiece 116. The slide control 126 is slidably movable within the channel 150 in the manner described above so as to continuously variably align the port 160 with the resistance window 128. In the embodiment of the slide control 126 illustrated in FIGS. 13, 16, and 17, a retaining ridge 162 fits into the channel 150 thereby holding the slide control 126 in its desired position throughout its range of motion in the mouthpiece. The desired position of the slide control 126 is as close as possible to the annular sealing ring 164 shown in FIG. 13. One function of the annular sealing ring 164 is to prevent leakage of the exhalant to ensure that the exhalant to the greatest extent exits from the resistance window 128. In a further embodiment, the PP valve 112 may optionally be provided with at least one locating ring or post 166 to help maintain the slide control 126 in alignment. As with the embodiment of FIGS. 1-3, a patient's exhalation effort is controlled by adjusting the slide control over the resistance window so that the patient's exhaled air, which is prevented from entering the aerosol chamber 114 by the annular valve 124 and a baffle (not shown), must exit through the resistance window and provide a desired exhalation resistance. More specifically, during inhalation the inner diameter 127 of the annular valve 124 (FIG. 11) unseats from the baffle (not shown) on the output end 122 of the aerosol holding chamber and permits passage of fluid. Substantially simultaneously, the exhalation flange 186 of the valve 124 flexes to seal against the outer ridge 188 (FIG. 13) formed inside the mouthpiece 116 to prevent ambient air from entering the mouthpiece. During exhalation, the process is reversed and the inner diameter 127 prevents exhalant from entering the aerosol holding chamber while the exhalation flange 186 flexes away from the outer ridge 188. Thus, the exhalant preferably passes through the resistance window 128 and may escape to the outside between the exhalation flange and the mouthpiece, and then through the gap between the mouthpiece and aerosol holding chamber.
Referring to FIGS. 18-21, an alternative embodiment of an assembly 210 for PEP therapy combined with an aerosol delivery apparatus is shown. The aerosol delivery apparatus includes a chamber housing 214 having an input end 220 and an output end 222. The chamber housing 214, input end 220, and output end 222 define an interior space 223. The apparatus may also include an elastomeric backpiece which may be similar to the backpiece in the embodiment shown in FIGS. 1-3. The output end 222 of the chamber housing 214 is shaped to receive the mouthpiece 216 and includes locking tabs 281 and a protrusion 283. The protrusion 283 is preferably annular in shape. The locking tabs 281 are spaced apart around the outside of the output end 222.
Referring to FIGS. 18-19, the mouthpiece assembly 216 is preferably substantially similar to that illustrated in FIGS. 10-15. The mouthpiece assembly includes an annular sealing ring 224, and a resistance window defined by a gap 225 in the sealing ring. A slide control 226 is slidably seated in a channel 250 between the annular sealing ring and support posts or a support ring. The tab setting 246 protrudes from the tab window 248 in the mouthpiece 216. The continuously variable resistance function is achieved as described above, using either embodiment of slide control and nozzle described above.
The mouthpiece assembly 216 is connected to the output end 222 of the chamber housing 214 by placing the apertures 284 over the locking tabs 281. As with the embodiment of FIGS. 1-3 and 10-17, in the embodiment of FIGS. 18-21 a containment baffle 275 may be integrally formed with the chamber housing 214 from a single piece of material and located near the outlet end 222. As shown in FIG. 18, the containment baffle 275 includes connecting members 276 that extend from the edge of the containment baffle to the inner diameter of the output end 222 in the chamber housing. Vents 277 are defined between the outer perimeter of the containment baffle and the inner diameter of the outlet end of the chamber housing and are separated by the connecting members. The vents 277 are arcuate in shape and conform to the outer perimeter of the containment baffle 275. In a preferred embodiment, the containment baffle is dome-shaped where the concave end points towards the chamber 223. In alternative embodiments, the containment baffle may be any of a number of geometric shapes.
A valve 278 having a valve member 279 and a valve seat 280 is shown. The valve seat 280 preferably comprises the rim of the valve and the corresponding raised lip 283 on the outlet end 222 of the chamber housing 214. The valve member has a sealing surface that preferably forms between two parallel portions, or lips, of the valve. In a preferred embodiment, the valve material seals against itself when fluid flows against a predetermined flow direction of the valve. In the embodiment shown, the valve is a duck-bill valve where the valve seat 280 is positioned axially away from the valve opening. The valve 278 defines a central open area toward the end having the valve seat. The valve member 279, shown as parallel sealing lips in FIGS. 18-21, acts to allow passage of fluid on inhalation, but upon exhalation, the lips of the valve member are held together by the force of fluid (e.g. exhaled air) pressing against the walls 285 of the valve member and collapsing the lips of the valve member 279 against each other in a closed position. The valve seat 280 also provides a seal against the chamber housing 214 during exhalation so that exhalant from a patient must be directed through the continuously variable resistance window in the mouthpiece.
In one preferred embodiment, the duck-bill valve 278 has a central open area 274 at its base that has a diameter of approximately 26.09 millimeters (mm). The width of the lips that form the valve member 279 is approximately 21.35 mm and the angle at which the walls 285 converge is approximately 72 degrees. Also, the height of the duck-bill valve 278 measured from the upper portion 282 of the valve seat to the valve member 279 is approximately 18.8 mm. The mouthpiece 216 for containing this valve 278 preferably includes a resistance widow gap 225 having a length of 59 degrees of arcuate cut in the annular sealing ring 224, where the annular sealing ring is approximately 31.4 mm in diameter and has a height of 4.5 mm.
The operation of the apparatus will now be discussed generally with reference to the embodiments of FIGS. 1-3, 10-17 and 18-21. At rest, the valve is adjacent to the output end of the chamber housing. In the annular valve embodiment of FIGS. 1-3 and 10-17 the inner portion of the valve covers the vents at the outlet end of the chamber housing. In the duck-bill embodiment of FIGS. 18-21, the entire outlet end is covered by the valve. For either valve embodiment, the mouthpiece and outlet end of the chamber housing traps the valve in place. Inhalation by the patient causes the sealing portion of the annular valve to move, or alternatively the lips of the duckbill valve to separate, and permit fluid to pass. Fluid from the chamber housing may be inhaled into the patient's respiratory system through the mouthpiece. The patient may then exhale into the mouthpiece.
Exhalation by the patient results in air traveling through the mouthpiece in a direction opposite the predetermined inhalation flow path of the valve. This air, which is blocked from passage through the valve along the inhalation path, then passes along a second path through the resistance window in the mouthpiece. Also, the force of the exhaled air causes the outer portion of the valve to move away from the mouthpiece in a direction towards the chamber housing. As a result, an exhalation pathway is created between the outer portion of the valve and the mouthpiece through which the exhaled air passes out to the atmosphere or some other predetermined location. As described above, the amount of effort that exhalation requires is set by the slide control, which may be set to block the appropriate amount of the resistance window to achieve the desired resistance.
Referring specifically to the duck-bill valve embodiment of FIGS. 18-21, the duck-bill valve 278 assists both in preventing inhalation of ambient air through the resistance window 225 and providing an exhalation path for exhalant. When the apparatus 210 is assembled (FIG. 19), the upper portion 282 of the valve seat seals against the annular sealing ring 224 except for the gap in the annular sealing ring 224 defining the resistance window 225. During inhalation, fluid flows through the central opening 274 and out the lips of the valve member 279. Also, the exhalation flange 286 flexes toward the proximal end of the mouthpiece and provides a secondary seal against the outer ridge 288 inside the mouthpiece. The outer ridge 288 is preferably continuous around the inner circumference of the mouthpiece. Upon exhalation, the lips of the valve member 279 close, the exhalant passes through the resistance window under the upper portion 282 of the valve seat positioned adjacent the resistance window opening, and the exhalation flange flexes away from the outer ridge 288 and out between the aerosol holding chamber 214 and mouthpiece 216.
As shown in FIGS. 22a-22c, an embodiment of an apparatus 310 for performing PEP therapy is disclosed that may be used with or without an aerosol delivery apparatus. In contrast to the embodiments discussed above, the PEP apparatus of FIGS. 22a-22c is a standalone PEP device in a mouthpiece incorporating the previously discussed continuous variable resistance window with slide control, and variations thereof, along with a self contained valve 378 that may be similar to that disclosed in the previous embodiments. Thus, the valve 378 need not be found on the outlet end of a separate chamber extension 314 but may be positioned on the distal end 330 of the mouthpiece. As best shown in FIGS. 22b-22c, the valve 378 may be an annular valve. The 378 is preferably retained toward the distal end 330 of the apparatus by a central baffle 385 supported by radial spokes 386. In one embodiment, the PEP apparatus 310 is formed of an attachable mouthpiece section 316 and a baffle section 317. The mouthpiece and baffle sections 316, 317 may be removably joined using snap-fit, threaded or other known attachment schemes. In another alternative embodiment, the mouthpiece and baffle sections 316, 317 may be integrally molded or welded shut to form a non-removable, unitary piece. An extended inlet 314, without any valves, may be used with the stand-alone PEP device 310 to enhance delivery of any medicine to the patient's respiratory system. One function of the extended inlet is to provide a chamber for the dispensed particles from the pressurized metered dose inhaler. When desired, a pressurized metered dose inhaler may be coupled to the extended inlet with a backpiece and medicament supplied from the pressurized metered dose inhaler can be delivered directly to the user.
Although the embodiments of FIGS. 1-22 illustrate annular and duck- bill valves 24, 124, 278, 378, any of a number of other valve configurations may be used. A preferred valve is capable of passing a fluid moving in a first direction along a first path and also capable of passing a fluid moving in an opposite direction along a second path. In the example valves discussed above, inhalation draws fluid through a central opening in the valve while the perimeter of the valve prevents fluid flow. In the above examples, exhalation closes the path through the central opening and directs fluid along a second path around the perimeter of the valve. Other paths may also be used.
FIGS. 23-28 illustrate another embodiment of a PEP apparatus 410. As best shown in FIG. 23, the PEP apparatus 410 has a patient respiratory system interface, such as a mouthpiece 416, on a proximal end 432 and may be connected with an aerosol delivery apparatus, in this example a nebulizer 414, at a distal end 430. The PEP apparatus includes a PP valve 412 positioned on top of the mouthpiece 416. The PP valve 412 preferably consists of a cover 417 that may be removably attached to a receiving area 419 (FIG. 24) on the mouthpiece 416. The cover has a resistance window 428 and a tab window 448 extending through a top surface. A slide control 426 in the form of a disk with vents 460 extending through the thickness of the disk is movably positioned under the cover 417. A one-way valve 423 is positioned between the slide control 426 and the top of the mouthpiece 416 to allow air exhaled into the proximal end 432 to escape through the resistance window 428 while preventing any air from entering through the resistance widow during inhalation.
In FIGS. 23-28, the resistance window 428 is shown generally as a pie-slice shaped cut-out with the point of the pie-slice removed so as to form a concave edge. The resistance window 428 may be any shape and should not be limited by the illustrated embodiment. Further, a plurality of resistance windows 428 may form the PP valve 412. The number of windows 428 is not intended to be limited by the illustrated embodiment. In the illustrated embodiment of FIGS. 23-28, and particularly FIG. 27, the slide control 426 is shown as a circular disc having a pie-slice shaped cut-outs with the point of the pie-slice openings therein which correspond to the openings of the resistance window 428. In operation, aligning the openings 460 of the disc with the resistance window 428 controls the opening of the continuously variable resistance window 428. When the resistance windows 428 are aligned with the disc openings 460, the resistance windows 428 are opened to their fullest extent allowing the resistance of the exhalant exiting the PP valve 412 to be lower. When only a small amount of the resistance windows 428 are aligned with the disc openings 460, the resistance of the exhalant exiting the PEP apparatus 410 is increased. By moving the tab setting 446 in the tab window 448, the vents may be adjusted in the disk 417 to any of a number of positions, thereby providing a continuously adjustable resistance. In this manner, positive expiratory pressure is controlled.
Referring again to FIG. 23, where the PEP apparatus 410 is connected at its distal end to the nebulizer 414, the operation of this embodiment will be described. Upon inhalation, the nebulizer will provide an aerosol to the inhaling patient via the mouthpiece. A suitable nebulizer for use with the PEP apparatus 410 is a breath-actuated nebulizer such as disclosed in U.S. Pat. No. 6,044,841 issued Apr. 4, 2000 and entitled “Breath Actuated Nebulizer with Valve Assembly Having Relief Piston”, the entirety of which is incorporated herein by reference. During inhalation from the nebulizer 414, a piston 452 is drawn down by negative pressure created by the inhalation in the nebulizer and ambient air is drawn through openings 454 in the lid 456 of the nebulizer 414. The one-way valve 459 in the PP valve assembly 412 remains shut during inhalation.
Upon exhalation into the proximal end 430 of the mouthpiece 416, a positive pressure builds in the nebulizer 414 and the piston acts as a one-way valve to close off the flow of air out of the nebulizer. Now, the exhalant must travel through the one-way valve in the PP valve assembly 412, through the slide control and out the resistance window. Preferably the slide control 426 under the resistance window 428 has been set to the appropriate position for the patient so that effective PEP therapy may be provided. Although the PEP apparatus of FIGS. 23-27 uses an aerosol delivery apparatus such as the nebulizer 414 to restrict air flow through any opening other than the PP valve assembly 412, other embodiments, such as shown in FIG. 29 discussed below, are contemplated where a second one-way valve is associated with the distal end 432 of the PEP apparatus 410 so that the PEP apparatus may be used in a standalone fashion for PEP therapy. The illustrated embodiment of FIGS. 23-28 show an improved nebulizer 414 associated with a PEP apparatus 410 having a PP valve 412. The nebulizer may be used alone or in combination with a mouthpiece mounted PP valve 412 or mask mounted version of the PP valve discussed below.
FIG. 29 shows an alternative embodiment of the PEP apparatus 410 of FIGS. 23-28 that may be used alone or coupled to a nebulizer or other aerosol delivery apparatus. As shown in FIG. 29. the mouthpiece 462 is provided with a one-way inhalation valve assembly 463 having a membrane 464 captured in an outlet cover 465 attached to the distal end 466 of the mouthpiece. The flexible membrane preferably covers vents in the outlet cover 465 during exhalation and flexes to allow fluid flow during inhalation. As with the embodiment of FIGS. 23-28, a PP valve assembly 467 is positioned on top of the mouthpiece. The PP valve assembly 467 differs from the PP valve assembly 412 in FIGS. 23-28 in that the slide control 468 contains a circular opening 469 that is moved by the tab setting 469 under a tear-drop shaped resistance window 471 in the cover 472. The inhalation valve 463 allows for fluid to enter the mouthpiece 462 but prevents fluid from exiting the mouthpiece. The exhalation valve 473 allows for exhalation through the resistance window 471 but prevents inhalation of particles or fluid. When assembled, a gap is present between the exhalation valve 473 and the slide control 468 in order to allow the exhalation valve 473 to open upon exhalation. In this manner, the mouthpiece 462 is adapted to be used alone and not in conjunction with a nebulizer or other aerosol delivery apparatus.
Although positive expiratory devices have been shown in detail, embodiments of positive inspiratory devices are also contemplated. FIG. 30 shows one embodiment, similar in concept to the embodiment of FIG. 29, but with the PP valve 475 attached in series with the one-way inhalation valve 476, rather than in series with the one-way exhalation valve, to provide for resistance upon inhalation only. The arrows drawn in FIG. 30 depict the direction of travel from the downstream end of the mouthpiece 478 to the upstream end of the mouthpiece showing that all inhalation must pass through the continuous variable resistance window 480 and the port 482 of the slide control 484. If desired, in other embodiments PP valves may be placed in series with both the one-way input and one-way output valves to allow for simultaneous control of positive inspiratory and expiratory pressures at the same or different levels.
As discussed above, embodiments of patient respiratory system interfaces aside from the mouthpiece configurations already disclosed are contemplated. A PP apparatus 510 utilizing a mask 512 as the interface is illustrated in FIGS. 31-35. The mask may be a standard mask sized for adults or children and constructed of any of a number of materials such as silicon rubber. The mask 512 may have a frustoconical shaped main section 514 sized to cover the patient's mouth and a nosepiece section 516 sized to cover a patient's nose. A central opening 518 in the mask 512 may be used to attach with an aerosol delivery apparatus such as the aerosol holding chamber 14 shown in FIGS. 1-3, and other aerosol delivery apparatus. Alternatively, the mask 512 may be fitted with a one-way valve in the central opening 518 for use as either a positive expiratory pressure device or a positive inspiratory pressure device. As with the embodiment of FIGS. 23-28 and 29-30, a PP valve assembly 520 is positioned on the device so that inspiration and exhalation paths travel off-axis from one another. The PP valve assembly 520 has an adjustable valve assembly cover 534 with tab window 522 and resistance window 528 openings positioned on it. The resistance window 528 is generally an oblong, tear-drop shape and the tab window 522 defines an arcuate opening in the PP valve cover 534. The tab window and resistance window may alternatively be rectangular, oval or any other shape. Although the above embodiments illustrate a tab window 522 located approximately on a top surface of a mouthpiece or on top of a mask positioned approximately adjacent the nose, the tab window 522 may be located anywhere on the mouthpiece or mask.
Referring to FIGS. 35a and 35b, the PP valve assembly 520 has a fixed opening 530 and a set of detents 532 positioned on a disk-shaped platform 526 that connects to the nosepiece section of the mask through complementary tab 542 and slot 544 connectors. As best shown in FIG. 35b, the PP valve cover 534 has a protrusion 536 sized to cooperate with the detents 532 on the platform 526 so that the valve cover may be moved to predetermined spots when the valve cover is rotated against the platform. An axle 538 on the valve cover fits into a central opening 540 in the platform 526 so that the resistance window 528 is rotatably positionable over the exhalation port 530 and the tab window 522 lines up with the tab extending from the platform 526.
This embodiment depicts the resistance window 528 as a curved tear-drop like shape. The platform 526 is shown as a circular disc having at least one port opening 530. The port opening 530 may vary in size and shape. The opening formed for the exhalant to pass through is related to the alignment of the resistance window 528 with the port opening 530. In this embodiment, the resistance window is moveably mounted relative to a fixed slide control portion attached to the mask. Tabs 542 on the platform 526 preferably mate with tab receiving regions 544 on the end of the nosepiece section 516 to retain the platform in a fixed position relative to the mask. Moving the tear-drop shaped resistance window 528 past the part opening 530 vanes the exhalant path. In other embodiments, a plurality of resistance window openings 528 may be moved past the port 530. Alternatively, there may be a plurality of ports in the slide control 526.
As shown in FIGS. 31 and 32a, one end of the tear-drop shaped resistance window 528 matches the size of the largest port opening 530 at a maximum flow position thereby providing a maximum flow and least resistance in that position. When the valve cover is rotated so that the resistance window 528 covers a greater portion of the port, as shown in FIGS. 33a-33b, a smaller exhalant path is created providing greater resistance. As shown in FIGS. 34a-34b, moving the valve cover until the tab reaches the opposite end of the tab window results in the smallest amount of the port being open, the highest airflow resistance and the least flow. It is envisioned that a plurality of size and shape port openings and resistance windows may be used and the disclosure is not to be limited to that depicted in the drawings. Referring to FIG. 36, an embodiment is shown of a valve cover 550 having indicia 552 representative of a resistance setting. The indicia 552 are arranged to cooperate with the tab extension 554 on the platform to indicate the current resistance setting.
In alternative embodiments, PEP therapy maybe performed with a mouthpiece or mask having the PP valve associated with a backpiece. The mask or mouthpiece may have an extended inlet for association with the backpiece.
Asthmatic medications are commonly supplied in metered dose inhalers, frequently referred to as pressurized metered dose inhalers. Pressurized metered dose inhalers are generally cylindrical canisters 700, as shown in FIG. 18, with axially extending vent tubes from internal valves. When the external tube or stem of a pressurized metered dose inhaler canister 700 is depressed it operates the internal valve to dispense a measured dose of medicine from the stem. The medicine is commonly packed in the canister with a suitable compressed gas to propel the medicine and gas from the stem or tube when the later is depressed. The medicine may be in gas, liquid, or solid form. The manufacturer or distributor of the pressurized metered dose inhaler canister generally supplies it with a substantially L-shaped adapter 602 which receives the canister in a substantially upright position, and has a substantial horizontal outlet portion for reception in the mouth of an asthmatic patient for inhalation of the medicine.
In order to address the problem of coordination and other problems known in the art with regard to pressurized metered dose inhalers, a spacer chamber with an integrated actuator, or an aerosol holding chamber, have been used in attempts to overcome inappropriate particle size. The aerosol holding chamber is generally provided at the upstream or entering end with a flexible, resilient adapter or backpiece made of rubber or the like material. A central aperture is provided for receipt of the horizontal outlet portion of the pressurized metered dose inhaler adapter.
One embodiment provides for an improved pressurized metered dose inhaler or pressurized metered dose inhaler with an aerosol holding chamber. As shown in FIG. 37, a PP apparatus 600 may be associated with the pressurized metered dose inhaler or the pressurized metered dose inhaler with an aerosol holding chamber. In the PP apparatus 600 of FIGS. 37-39, an L-shaped adapter portion 602 holds the pressurized canister and a horizontal outlet section 604 receives the medicament released in aerosol form. A one-way valve 606, which may be a flexible membrane, a rigid membrane, hinged door, or other commonly known valve mechanism is positioned at the proximal end 608 of the horizontal outlet section 604. To provide the positive expiratory pressure, the one-way valve 606 permits inhalation and blocks exhalation so that substantially all exhalation is routed through the variable resistance window 610 adjacent the one-way valve 606. A slide control 612 is movable in the resistance window 610 by a tab 614 to close off or open up as much of the resistance window as necessary to provide the desired expiratory pressure. FIGS. 38a and 39a illustrate the slide control in a completely open position and FIGS. 38b and 39b illustrate the slide control closing off the resistance window. The slide control may maintain its position in the resistance window through friction, detents or other known mechanisms for mechanically retaining one of multiple desired positions. The proximal end 608 of the metered dose inhaler 600 with PP functionality may be used by a patient directly or fitted to an adapter on an aerosol chamber such as shown in FIG. 3. FIG. 40 illustrates another embodiment of a pressurized metered does inhaler 620 with a round proximal end 628 that may be used without the need for special mouthpieces or aerosol holding chambers. As with the embodiment of FIGS. 37-39, the alternative PEP enabled pressurized metered dose inhaler 620 has a one-way valve 626 that shunts exhalant through a resistance window 622 that is continuously adjustable with a slide control 624 that can adjust the aperture of the resistance window.
Generally, a mouthpiece or mask may be associated the PP apparatus. In one configuration, an aerosol holding chamber may be attached to the mouthpiece or mask end and a metered dose inhaler may be positioned on a generally opposite end of the chamber via a backpiece. The user of the device may insert the mouthpiece into the mouth to obtain a dose of medicament. Further, the user may place the mask over the mouth and/or nose to inspire a dose of the medicament. In either situation, the mask or mouthpiece aids in the delivery of the medicament to the user.
As has been described, a method and apparatus from providing positive expiration or inhalation therapy, with or without separate aerosol generating devices, has been disclosed. In the embodiment where the positive expiratory pressure valve is located at or near the output end of the aerosol delivery apparatus, a one way inhalation valve can be located further downstream from the positive expiratory pressure valve. A mouthpiece and or mask can be affixed at or near the output end of the aerosol delivery apparatus. The positioning of the inhalation valve either upstream or downstream in respect to the positive expiratory pressure valve is well known to one skilled in the art. Further, it is envisioned that PEP therapy may be performed nasally with the positive expiratory pressure apparatus.
When the mouthpiece having the PP apparatus associated therewith is used alone to perform PEP therapy, and not in conjunction with a mechanism for the delivery of a substance, a one way inhalation valve is engageable with the mouthpiece. The inhalation valve functions so as to allow for inhalation by the patient into the mouthpiece. The exhalant of the patient is prevented from exiting via the inhalation valve and is directed to exit through the PP valve. Generally, an inhalation valve opens upon inhalation to allow a fluid, such as an aerosol, to enter a chamber or channel or the like but that closes upon exhalation to prevent exhaled fluids to enter into the chamber of the like. The drawings depict an exemplary embodiment of the one-way inhalation valve but are not to be limiting to the embodiments shown.
One aspect of the method of use of the PP apparatus can be understood by the following disclosure and reference to FIGS. 1-3, 5 and 9. Particularly, the arrow 2 in FIG. 1 indicates the direction of flow of the exhalant. The one-way valve shunts exhalant out between the mouthpiece and the aerosol chamber via the continuously variable resistance window. In carrying out the method, a physician may initially determine the proper resistance setting of the PP apparatus according to the patient's requirements. One manner in which the PP apparatus may be properly set is by attaching a fitting 39 to the mouthpiece. A manometer is then attached to the fitting port 41 and serves to measure the expiratory pressure. A patient will exhale into the mouthpiece and the pressure can be read from the manometer. The physician can the move the tab to one of the desired settings indicated on the mouthpiece. Once the proper resistance has been determined the fitting 39 can be removed from the mouthpiece. This fitting 39 will not be used again unless it is determined that the resistance should be adjusted.
The method of performing PEP therapy using the PP apparatus includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a medicament may be provided for inhalation into the respiratory system. In one embodiment of PEP therapy, the user will exhale into the mouthpiece and/or mask, against the desired resistance. This is done either prior to or in combination with inhalation of the medicament. The exhaled gases exit through the resistance window. This process may be repeated as many times as prescribed by the patient's physician.
As has been described, a method and apparatus for providing positive expiration, or inhalation, pressure therapy, with or without separate aerosol generating devices, has been disclosed. The aerosol delivery apparatus with the PP apparatus may be used alone or in combination with a mask or mouthpiece. Also, an improved aerosol delivery apparatus with an integrated actuator has been shown, wherein the improvement comprises a PP valve. The discussion above is descriptive, illustrative and exemplary and is not to be taken as limiting the scope defined by any appended claims.

Claims (50)

What is claimed is:
1. A positive respiratory pressure apparatus comprising:
a patient respiratory system interface;
a one-way valve positionable in the patient respiratory interface and configured to pass a fluid traveling in a predetermined direction from a first side to a second side of the one-way valve; and
wherein the patient respiratory system interface comprises a bypass window integral with, and defined by, the patient respiratory interface, the bypass window positioned adjacent the one-way valve, and wherein the patient respiratory interface further comprises a window opening adjustment mechanism movably disposed in the patient respiratory system interface and operable to change a size of an opening between the patient respiratory system interface and ambient air outside of the patient respiratory system interface, whereby the bypass window and window opening adjustment mechanism cooperate to selectively create one of a plurality of fluid resistances.
2. The apparatus of claim 1, wherein the bypass window and window opening adjustment mechanism are configured to cooperate with the one-way valve to provide an inspiratory pressure at the patient respiratory system interface.
3. The apparatus of claim 1, wherein the bypass window and window opening adjustment mechanism are movable into a plurality of overlapping positions.
4. The apparatus of claim 3, wherein the window opening adjustment mechanism comprises a tapered portion, and wherein the size of the opening is defined by an overlap position of the tapered portion relative to the bypass window.
5. The apparatus of claim 1, wherein an edge of the window opening adjustment mechanism is movable to overlap an edge wall of the bypass window at a non-perpendicular angle.
6. The apparatus of claim 1, wherein the fluid traveling in the predetermined direction comprises inhaled gas and the one-way valve comprises a one-way inhalation valve, and wherein the one-way inhalation valve is configured to cooperate with the bypass window and window opening adjustment mechanism to create a positive expiratory pressure at the patient respiratory system interface.
7. The apparatus of claim 6, wherein the window opening adjustment mechanism is positioned over the bypass window.
8. The apparatus of claim 6, wherein the window opening adjustment mechanism is positioned beneath the bypass window.
9. The apparatus of claim 8, wherein the bypass window comprises an opening in a curved wall formed in the patient respiratory interface, and the window opening adjustment mechanism is movably positioned adjacent the opening in the circular wall.
10. The apparatus of claim 6, wherein the opening defined by the bypass window and window opening adjustment mechanism is continuously adjustable between a first exhalation resistance and a second exhalation resistance.
11. The apparatus of claim 1, wherein the patient respiratory system interface comprises a mouthpiece.
12. The apparatus of claim 1, wherein the patient respiratory system interface comprises a mask.
13. The apparatus of claim 1, wherein the patient respiratory system interface is integrally formed with a metered dose inhaler.
14. The apparatus of claim 13, wherein the patient respiratory system interface defines a circular opening at a proximal end.
15. The apparatus of claim 13, wherein the patient respiratory system interface defines an oblong opening at a proximal end.
16. The apparatus of claim 13, wherein the bypass window is oriented perpendicular to the one-way valve.
17. The apparatus of claim 1, wherein the one-way valve comprises a duck-bill valve.
18. The apparatus of claim 1, wherein the one-way valve comprises an annular valve.
19. The apparatus of claim 1, further comprising an aerosol delivery apparatus in fluid communication with the patient respiratory interface.
20. The apparatus of claim 19, wherein the aerosol delivery apparatus comprises a nebulizer.
21. The apparatus of claim 19, wherein the aerosol delivery apparatus comprises an aerosol holding chamber.
22. A respiratory apparatus comprising:
a holding chamber having an input end and an output end and defining a longitudinal flow axis therebetween, the longitudinal flow axis extending in a longitudinal direction;
a patient respiratory system interface comprising a mouthpiece member and a retainer member, wherein the retainer member is disposed adjacent the output end of the holding chamber and wherein the mouthpiece member comprises an annular wall extending in a longitudinal direction and surrounding the longitudinal flow axis;
an inhalation flow control member positionable in the patient respiratory interface between the mouthpiece member and the retainer member, wherein the inhalation flow control member is self-contained in the patient respiratory system interface and is sealed between the mouthpiece member and the retainer member; and
an exhalation flow control member separate from the inhalation flow control member and moveably coupled to the mouthpiece member of the patient respiratory system interface, wherein the exhalation flow control member extends in the longitudinal direction;
wherein the patient respiratory system interface comprises an expiratory path window integral with, and defined by, the mouthpiece member of the patient respiratory system interface, wherein the expiratory path window is formed in the annular wall of the mouthpiece member, and wherein the exhalation flow control member is moveable between a first position, wherein at least a portion of the expiratory path window is open such that exhaust gases can escape through the expiratory path window during exhalation, and a second position, wherein the exhalation flow control member is positioned over and closes the expiratory path window.
23. The respiratory apparatus of claim 22 wherein the inhalation flow control member comprises a duck-bill valve.
24. The respiratory apparatus of claim 22 wherein the retainer member comprises an annular wall fitting over and mating with an annular shoulder formed on the output end of the holding chamber.
25. The respiratory apparatus of claim 22 wherein the retainer member is releasably coupled to the mouthpiece member.
26. The respiratory apparatus of claim 22 wherein the retainer member is coupled to the mouthpiece member with a snap-fit.
27. The respiratory apparatus of claim 22 wherein the retainer member is coupled to the mouthpiece member with a friction fit.
28. The respiratory apparatus of claim 22 wherein the mouthpiece and retainer members are permanently joined.
29. The respiratory apparatus of claim 22 further comprising an aerosol delivery device containing a medicament coupled to the input end of the holding chamber.
30. The respiratory apparatus of claim 29 wherein the aerosol delivery device comprises a pressurized metered dose inhaler.
31. The respiratory apparatus of claim 22 wherein the annular wall is non-circular.
32. The respiratory apparatus of claim 22 wherein the exhalation flow control member comprises a retaining portion secured to the mouthpiece member.
33. The respiratory apparatus of claim 32 wherein the retaining portion comprises a ridge fitting into a channel formed in the mouthpiece member.
34. The respiratory apparatus of claim 32 wherein the exhalation flow control member extends in the longitudinal direction from said retaining portion toward the input end of the holding chamber.
35. A respiratory apparatus comprising:
a holding chamber having an input end and an output end and defining a longitudinal flow axis therebetween, the longitudinal flow axis extending in a longitudinal direction;
a patient respiratory system interface comprising a mouthpiece member and a retainer member, wherein the retainer member is disposed adjacent the output end of the holding chamber, wherein the mouthpiece member comprises an annular wall extending in a longitudinal direction and surrounding the longitudinal flow axis, and wherein the mouthpiece member comprises a front wall facing the user and extending transverse to the longitudinal direction;
an inhalation flow control member positionable in the patient respiratory interface between the mouthpiece member and the retainer member; and
an exhalation flow control member separate from the inhalation flow control member and moveably coupled to the mouthpiece member of the patient respiratory system interface, wherein the exhalation flow control member extends in the longitudinal direction;
wherein the patient respiratory system interface comprises an expiratory path window integral with, and defined by, the mouthpiece member of the patient, respiratory system interface, wherein the expiratory path window is formed in the annular wall of the mouthpiece member, and wherein the exhalation flow control member is moveable between a first position, wherein at least a portion of the expiratory path window is open such that exhaust gases can escape through the expiratory path window during exhalation, and a second position, wherein the exhalation flow control member is positioned over and closes the expiratory path window, and wherein the exhalation flow control member comprises a portion extending through the front wall of the mouthpiece member so as to be exposed to a user.
36. The respiratory apparatus of claim 28 wherein the mouthpiece and retainer members are bonded.
37. A respiratory apparatus comprising:
a holding chamber having an input end and an output end and defining a longitudinal flow axis therebetween, the longitudinal flow axis extending in a longitudinal direction;
a patient respiratory system interface comprising a mouthpiece member and a retainer member, wherein the retainer member is disposed adjacent to the output end of the holding chamber;
an inhalation flow control member positionable in the patient respiratory interface between the mouthpiece member and the retainer member, wherein the inhalation flow control member is self-contained in the patient respiratory system interface and is sealed between the mouthpiece member and the retainer member, the inhalation flow control member comprising a base portion having a center hole, wherein said base portion remains stationary relative to the longitudinal direction during inhalation; and
an exhalation flow control member separate from the inhalation flow control member and moveably coupled to the mouthpiece member of the patient respiratory system interface, wherein the exhalation flow control member extends in the longitudinal direction:
wherein the patient respiratory system interface comprises an expiratory path window integral with, and defined by, the mouthpiece member of the patient respiratory system interface, wherein said expiratory path window is formed in a wall extending in the longitudinal direction, and wherein the exhalation flow control member is moveable between a first position, wherein at least a portion of the expiratory path window is open such that exhaust gases can escape through the expiratory path window during exhalation, and a second position, wherein the exhalation flow control member is positioned over and closes the expiratory path window.
38. The respiratory apparatus of claim 37 wherein the inhalation flow control member comprises a duck-bill opening downstream of the center hole during inhalation.
39. The respiratory apparatus of claim 37 wherein the retainer member comprises an annular wall fitting over and mating with an annular shoulder formed on the output end of the holding chamber.
40. The respiratory apparatus of claim 37 wherein the retainer member is releasable coupled to the mouthpiece member.
41. The respiratory apparatus of claim 37 wherein the retainer member is coupled to the mouthpiece member with a snap-fit.
42. The respiratory apparatus of claim 37 wherein the retainer member is coupled to the mouthpiece member with a friction fit.
43. The respiratory apparatus of claim 37 wherein the mouthpiece and retainer members are permanently joined.
44. The respiratory apparatus of claim 43 wherein the mouthpiece and retainer members are bonded.
45. The respiratory apparatus of claim 37 further comprising an aerosol delivery device containing a medicament coupled to the input end of the holding chamber.
46. The respiratory apparatus of claim 50 wherein the aerosol delivery device comprises a pressurized metered dose inhaler.
47. The respiratory apparatus of claim 37 wherein the exhalation flow control member comprises a retaining portion secured to the mouthpiece member.
48. The respiratory apparatus of claim 47 wherein the retaining portion comprises a ridge fitting into a channel formed in the mouthpiece member.
49. The respiratory apparatus of claim 47 wherein the exhalation flow control member extends in the longitudinal direction from said retaining portion toward the input end of the holding chamber.
50. A respiratory apparatus comprising:
a holding chamber having an input end and an output end and defining a longitudinal flow axis therebetween, the longitudinal flow axis extending in a longitudinal direction;
a patient respiratory system interface comprising a mouthpiece member and a retainer member, wherein the retainer member is disposed adjacent to the output end of the holding chamber, and wherein wherein the mouthpiece member comprises a front wall facing the user and extending transverse to the longitudinal direction;
an inhalation flow control member positionable in the patient respiratory interface between the mouthpiece member and the retainer member, the inhalation flow control member comprising a base portion having a center hole, wherein said base portion remains stationary relative to the longitudinal direction during inhalation and
an exhalation flow control member separate from the inhalation flow control member and moveably coupled to the mouthpiece member of the patient respiratory system interface, wherein the exhalation flow control member extends in the longitudinal direction;
wherein the patient respiratory system interface comprises an expiratory path window integral with, and defined by, the mouthpiece portion of the patient respiratory system interface, wherein said expiratory path window is formed in a wall extending in the longitudinal direction, and wherein the exhalation flow control member is moveable between a first position, wherein at least a portion of the expiratory path window is open such that exhaust gases can escape through the expiratory path window during exhalation, and a second position, wherein the exhalation flow control member is positioned over and closes the expiratory path window, and wherein the exhalation flow control member comprises a portion extending through the front wall of the mouthpiece member so as to be exposed to a user.
US13/371,787 2000-04-11 2012-02-13 Aerosol delivery apparatus Expired - Lifetime USRE45068E1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/371,787 USRE45068E1 (en) 2000-04-11 2012-02-13 Aerosol delivery apparatus
US14/340,146 USRE46050E1 (en) 2000-04-11 2014-07-24 Aerosol delivery apparatus

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19655500P 2000-04-11 2000-04-11
US09/833,019 US6557549B2 (en) 2000-04-11 2001-04-11 Aerosol delivery apparatus with positive expiratory pressure capacity
US10/389,257 US6848443B2 (en) 2000-04-11 2003-03-14 Aerosol delivery apparatus with positive expiratory pressure capacity
US11/655,039 USRE43174E1 (en) 2000-04-11 2007-01-18 Aerosol delivery apparatus
US13/371,787 USRE45068E1 (en) 2000-04-11 2012-02-13 Aerosol delivery apparatus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/389,257 Reissue US6848443B2 (en) 2000-04-11 2003-03-14 Aerosol delivery apparatus with positive expiratory pressure capacity

Publications (1)

Publication Number Publication Date
USRE45068E1 true USRE45068E1 (en) 2014-08-12

Family

ID=22725866

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/833,019 Expired - Lifetime US6557549B2 (en) 2000-04-11 2001-04-11 Aerosol delivery apparatus with positive expiratory pressure capacity
US10/389,257 Ceased US6848443B2 (en) 2000-04-11 2003-03-14 Aerosol delivery apparatus with positive expiratory pressure capacity
US11/655,039 Expired - Lifetime USRE43174E1 (en) 2000-04-11 2007-01-18 Aerosol delivery apparatus
US13/371,787 Expired - Lifetime USRE45068E1 (en) 2000-04-11 2012-02-13 Aerosol delivery apparatus
US14/340,146 Expired - Lifetime USRE46050E1 (en) 2000-04-11 2014-07-24 Aerosol delivery apparatus

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/833,019 Expired - Lifetime US6557549B2 (en) 2000-04-11 2001-04-11 Aerosol delivery apparatus with positive expiratory pressure capacity
US10/389,257 Ceased US6848443B2 (en) 2000-04-11 2003-03-14 Aerosol delivery apparatus with positive expiratory pressure capacity
US11/655,039 Expired - Lifetime USRE43174E1 (en) 2000-04-11 2007-01-18 Aerosol delivery apparatus

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/340,146 Expired - Lifetime USRE46050E1 (en) 2000-04-11 2014-07-24 Aerosol delivery apparatus

Country Status (6)

Country Link
US (5) US6557549B2 (en)
EP (1) EP1272243B1 (en)
AU (1) AU4867001A (en)
CA (4) CA2406185C (en)
DE (1) DE60114393T2 (en)
WO (1) WO2001076671A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130186393A1 (en) * 2010-09-21 2013-07-25 Koninklijke Philips Electronics N.V. Valved holding chamber including valve retention system
USD724592S1 (en) * 2014-02-21 2015-03-17 Amazon Technologies, Inc. Scanner device
USD744636S1 (en) * 2013-02-14 2015-12-01 Clement Clarke International Limited Spacer for inhaler
USD760952S1 (en) * 2013-12-10 2016-07-05 Michael James Mayor Electronic cigarette tank with fill port and plug
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery
US9814849B2 (en) 2002-05-21 2017-11-14 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
USD807320S1 (en) * 2015-05-19 2018-01-09 Gibson Innovations Belgium Nv Portable bluetooth speaker
USD853984S1 (en) * 2017-11-10 2019-07-16 Scosche Industries, Inc. Wireless mobile speaker
USD866559S1 (en) * 2016-11-11 2019-11-12 Samsung Electronics Co., Ltd. SSD storage device
USD886770S1 (en) * 2017-10-09 2020-06-09 Sunchon Development (Shenzhen) Co., Ltd. Sound box
US11577033B2 (en) 2018-06-05 2023-02-14 Medline Industries, Lp Valved spacer for inhalation device
USD990447S1 (en) * 2018-06-29 2023-06-27 Logitech Europe S.A. Portable speaker

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5823179A (en) * 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
CA2406185C (en) 2000-04-11 2011-03-15 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
ES2375333T3 (en) * 2001-03-20 2012-02-28 Trudell Medical International NEBULIZING DEVICE.
US6994083B2 (en) * 2001-12-21 2006-02-07 Trudell Medical International Nebulizer apparatus and method
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
US20030205226A1 (en) 2002-05-02 2003-11-06 Pre Holding, Inc. Aerosol medication inhalation system
US7267120B2 (en) * 2002-08-19 2007-09-11 Allegiance Corporation Small volume nebulizer
WO2004037108A1 (en) * 2002-10-23 2004-05-06 Kaltenbach & Voigt Gmbh & Co. Kg Tube for a medical or dental handpiece for spraying an abrasive flow medium
US7360537B2 (en) * 2003-04-16 2008-04-22 Trudell Medical International Antistatic medication delivery apparatus
US7748385B2 (en) * 2003-05-23 2010-07-06 Ric Investments, Inc Valved holding chamber for use with an aerosol medication delivery system
US7191781B2 (en) * 2003-08-05 2007-03-20 Innomed Technologies, Inc. Nasal ventilation interface and system
DE10345950A1 (en) * 2003-10-02 2005-05-19 Pari GmbH Spezialisten für effektive Inhalation Inhalation therapy device with valve
DE10352277A1 (en) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US9022027B2 (en) 2004-02-20 2015-05-05 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
US8109266B2 (en) 2004-02-20 2012-02-07 Pneumoflex Systems, Llc Nebulizer having flow meter function
CA2557020A1 (en) * 2004-02-24 2005-09-01 Boehringer Ingelheim International Gmbh Atomiser
US7709639B2 (en) 2004-08-20 2010-05-04 Mannkind Corporation Catalysis of diketopiperazine synthesis
EP1791542B1 (en) 2004-08-23 2015-05-20 Mannkind Corporation Diketopiperazine salts for drug delivery
EP1629859A1 (en) * 2004-08-27 2006-03-01 John Storey Talbot Face mask
DE102005042182B4 (en) * 2004-09-03 2016-01-21 Weinmann Geräte für Medizin GmbH & Co. KG Apparatus for ventilation
FR2875138B1 (en) * 2004-09-15 2008-07-11 Mallinckrodt Dev France Sa CONTROL METHOD FOR A HEATING HUMIDIFIER
WO2006055047A2 (en) * 2004-11-18 2006-05-26 Mark Adler Intra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor
WO2006100668A2 (en) * 2005-03-24 2006-09-28 Medihale Ltd. Aerosol medication delivery apparatus
SE531316C2 (en) * 2005-04-19 2009-02-17 Kenneth Eliasson An adjustable breathing resistance
DK1901749T3 (en) 2005-05-18 2016-10-24 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones AND USES THEREOF
US8524735B2 (en) * 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US9675109B2 (en) * 2005-07-19 2017-06-13 J. T. International Sa Method and system for vaporization of a substance
US11647783B2 (en) 2005-07-19 2023-05-16 Juul Labs, Inc. Devices for vaporization of a substance
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
ES2559677T3 (en) 2005-09-14 2016-02-15 Mannkind Corporation Drug formulation method based on increasing the affinity of the active ingredients for microcrystalline particle surfaces
US7629929B2 (en) * 2005-09-26 2009-12-08 Electronics And Telecommunications Research Institute Antenna using proximity-coupled feed method, RFID tag having the same, and antenna impedance matching method thereof
US7617821B2 (en) * 2005-11-23 2009-11-17 Vibralung, Inc. Acoustic respiratory therapy apparatus
GB0602897D0 (en) * 2006-02-13 2006-03-22 Jagotec Ag Improvements In Or Relating To Dry Powder Inhaler Devices
KR20080096809A (en) 2006-02-22 2008-11-03 맨카인드 코포레이션 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
DE102006016901A1 (en) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006016904A1 (en) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
US7909033B2 (en) 2006-05-03 2011-03-22 Comedica Incorporated Breathing treatment apparatus
US20070283951A1 (en) * 2006-06-12 2007-12-13 Marc Alan Burk Mask-nebulizer assembly
US7793658B2 (en) 2006-08-21 2010-09-14 Go2 Llc Personal assistive breathing apparatus
MX2009001944A (en) 2006-08-21 2009-04-16 Trudell Medical Int Respiratory muscle endurance training device and method for the use thereof.
US20110030700A1 (en) * 2006-08-30 2011-02-10 Wilson John K Snoring Treatment and Associated Apparatus, System and Method
US7775211B2 (en) * 2006-08-30 2010-08-17 Wilson John K Snoring treatment and associated apparatus, system and method
US8051854B2 (en) * 2006-09-15 2011-11-08 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
US8225785B2 (en) * 2006-10-03 2012-07-24 Smiths Medical Asd, Inc. Vibratory PEP therapy system with medicated aerosol nebulizer
US20080087279A1 (en) * 2006-10-11 2008-04-17 Tieck Catharine Laureen Johnso Metered dose inhaler
US7779841B2 (en) 2006-11-13 2010-08-24 Carefusion 2200, Inc. Respiratory therapy device and method
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
BRPI0809602A2 (en) * 2007-04-02 2014-11-04 Allegiance Corp RESPIRATORY THERAPY DEVICE AND SYSTEM
WO2008124666A2 (en) * 2007-04-06 2008-10-16 Becton, Dickinson And Company Disposable spacer for inhalation delivery of aerosolized drugs and vaccines
US9050434B2 (en) * 2007-05-18 2015-06-09 Comedica Incorporated Lung therapy device
BRPI0814248A2 (en) * 2007-06-15 2015-01-06 Boehringer Ingelheim Int INHALER
US20090064996A1 (en) * 2007-09-10 2009-03-12 Rosh Melvin S Duo chamber
DK2230934T3 (en) 2007-12-14 2012-11-26 Aerodesigns Inc Release of aerosolizable food products
EP2259849A2 (en) 2008-02-21 2010-12-15 Trudell Medical International Respiratory muscle endurance training device and method for the use thereof
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US8539951B1 (en) 2008-05-27 2013-09-24 Trudell Medical International Oscillating positive respiratory pressure device
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA3086027C (en) 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
DK2300083T3 (en) 2008-06-20 2013-07-22 Mannkind Corp INTERACTIVE DEVICE AND PROCEDURE FOR REAL-TIME PROFILING INHALATION TESTS
US20100000523A1 (en) * 2008-07-07 2010-01-07 Rosh Melvin S Unichamber
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
BRPI0912918B8 (en) 2008-08-25 2021-06-22 Koninklijke Philips Electronics Nv respiratory drug delivery device, and method of encouraging the use of a respiratory drug delivery device
SG194406A1 (en) * 2008-10-07 2013-11-29 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics
HUE050147T2 (en) * 2008-10-07 2020-11-30 Horizon Orphan Llc Inhalation of levofloxacin for reducing lung inflammation
US8327849B2 (en) * 2008-10-28 2012-12-11 Trudell Medical International Oscillating positive expiratory pressure device
US20110232636A1 (en) * 2008-12-18 2011-09-29 Koninklijke Philips Electronics, N.V. Valved holding chamber and mask therefor
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8485179B1 (en) 2009-02-23 2013-07-16 Trudell Medical International Oscillating positive expiratory pressure device
US9149589B2 (en) 2009-02-23 2015-10-06 Trudell Medical International Method and device for performing orientation dependent oscillating positive expiratory pressure therapy
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
BRPI1013154B1 (en) 2009-06-12 2020-04-07 Mannkind Corp MICROPARTICLES OF DICETOPIPERAZINE WITH SPECIFIC SURFACE AREAS DEFINED, DRY POWDER UNDERSTANDING THE REFERRED MICROPARTICLES, METHOD FOR FORMATION OF THE REFERENCESMICROPARTICLES AND THE FORMATION OF MICROPARTYSTEMS
HUE045469T2 (en) 2009-09-04 2019-12-30 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US20110100360A1 (en) * 2009-11-02 2011-05-05 Joseph Dee Faram Composite lung therapy device and method
US9151425B2 (en) * 2009-11-02 2015-10-06 Comedica Incorporated Multiple conduit connector apparatus and method
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US9352107B2 (en) 2010-01-07 2016-05-31 Koninklijke Philips N.V. Respiratory drug delivery apparatus including a feedback and compliance device
DE102010008923B4 (en) * 2010-02-23 2013-09-19 Dräger Safety AG & Co. KGaA Directional valve for a respiratory protection product
NL2004434C2 (en) * 2010-03-19 2011-09-20 Rob Janssen Oropharyngeal training tool and training method.
RU2531455C2 (en) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Systems and methods for dry powder drugs delivery
US11247003B2 (en) 2010-08-23 2022-02-15 Darren Rubin Systems and methods of aerosol delivery with airflow regulation
US8678005B2 (en) * 2010-10-26 2014-03-25 Dawson Medical Technologies Llc Adjustable tracheostomy valve
AU333977S (en) * 2010-11-10 2010-12-03 Medical Developments International Ltd Valve for a spacer
US8671934B2 (en) 2011-01-20 2014-03-18 Pneumoflex Systems, Llc Nebulizer that is activated by negative inspiratory pressure
US9452270B2 (en) 2011-01-20 2016-09-27 Pneumoflex Systems, Llc Nebulizer having replaceable nozzle assembly and suction line
US20140202457A1 (en) 2011-01-20 2014-07-24 Pneumoflex Systems, Llc Metered dose nebulizer
EP2670242B1 (en) 2011-01-31 2022-03-16 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US20120247474A1 (en) * 2011-03-29 2012-10-04 Steve Gordon Torbenson Face mask apparatus and system
MX353285B (en) 2011-04-01 2018-01-05 Mannkind Corp Blister package for pharmaceutical cartridges.
CA3010658C (en) 2011-06-06 2020-12-01 Trudell Medical International Oscillating positive expiratory pressure device
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EA037480B1 (en) 2011-08-16 2021-04-01 Джуул Лэбз, Инк. Low temperature electronic vaporization device
KR20140095483A (en) 2011-10-24 2014-08-01 맨카인드 코포레이션 Methods and compositions for treating pain
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
FR2988461B1 (en) * 2012-03-22 2014-04-18 Protecsom DUCK-TYPE TYPE VALVE AND INHALATION DEVICE COMPRISING SUCH A VALVE
US9364622B2 (en) 2012-04-20 2016-06-14 Fsc Laboratories, Inc. Inhalation devices and systems and methods including the same
RU2650035C2 (en) 2012-07-12 2018-04-06 Маннкайнд Корпорейшн Dry powder drug delivery systems and methods
EP2877164B1 (en) 2012-07-24 2023-07-05 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US9517315B2 (en) 2012-11-30 2016-12-13 Trudell Medical International Oscillating positive expiratory pressure device
US9795752B2 (en) 2012-12-03 2017-10-24 Mhs Care-Innovation, Llc Combination respiratory therapy device, system, and method
USD735316S1 (en) * 2013-03-11 2015-07-28 Fsc Laboratories, Inc. Inhalation spacer
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
CN105102436B (en) 2013-03-15 2018-06-12 曼金德公司 Crystallite diketopiperazine composition and method
USD753284S1 (en) * 2013-06-12 2016-04-05 M. LaQuisha Burks Expiratory muscle strength trainer adapter
US10207065B2 (en) 2013-07-12 2019-02-19 John H. Silva Mouthpiece for inhalers
EP3466396B1 (en) 2013-07-12 2020-09-09 Trudell Medical International Huff cough simulation device
KR102321339B1 (en) 2013-07-18 2021-11-02 맨카인드 코포레이션 Heat-stable dry powder pharmaceutical compositions and methods
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
PL3035886T3 (en) 2013-08-20 2021-05-31 Boehringer Ingelheim Vetmedica Gmbh Inhaler
ES2960809T3 (en) 2013-08-20 2024-03-06 Boehringer Ingelheim Vetmedica Gmbh Inhaler
WO2015024652A1 (en) * 2013-08-20 2015-02-26 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US9849257B2 (en) 2013-08-22 2017-12-26 Trudell Medical International Oscillating positive respiratory pressure device
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
CN115281387A (en) 2013-12-23 2022-11-04 尤尔实验室有限公司 Evaporation apparatus system and method
US10363383B2 (en) 2014-02-07 2019-07-30 Trudell Medical International Pressure indicator for an oscillating positive expiratory pressure device
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
USD748242S1 (en) * 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
GB201412867D0 (en) * 2014-07-19 2014-09-03 Smiths Medical Int Ltd Respiratory therapy devices
US11413408B2 (en) 2014-07-29 2022-08-16 Peter Edenhoffer Positive pressure inspiration device for delivery of medicaments
CA160775S (en) 2014-08-11 2015-09-29 Ploom Inc Electronic vaporization device with cartridge
US10434277B2 (en) 2014-08-14 2019-10-08 Rbt Medical Products Llc Positive expiratory pressure device and methods of using same
EP2997991A1 (en) * 2014-09-19 2016-03-23 Koninklijke Philips N.V. Device for providing supplemental oxygen to a subject
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3212082B1 (en) * 2014-10-31 2019-12-11 Connected Rock, Inc. Oral appliance for ventilation flow measurement
UA124185C2 (en) 2014-12-05 2021-08-04 Джуул Лебз, Інк. Calibrated dose control
WO2016119018A1 (en) * 2015-01-30 2016-08-04 Resmed Asia Operations Pty Limited Patient interface comprising a gas washout vent
US10004872B1 (en) 2015-03-06 2018-06-26 D R Burton Healthcare, Llc Positive expiratory pressure device having an oscillating valve
US10905836B2 (en) 2015-04-02 2021-02-02 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
EP3730176B1 (en) * 2015-07-20 2023-11-15 Fisher & Paykel Healthcare Limited Exhalation port
CA2994792C (en) 2015-07-30 2023-06-06 Trudell Medical International Combined respiratory muscle training and oscillating positive expiratory pressure device
USD779071S1 (en) 2015-08-14 2017-02-14 Christopher D. Warner, III Positive expiratory pressure device
USD778429S1 (en) 2015-09-02 2017-02-07 Trudell Medical International Respiratory treatment device
USD780906S1 (en) 2015-09-02 2017-03-07 Trudell Medical International Respiratory treatment device
WO2017093966A1 (en) 2015-12-04 2017-06-08 Trudell Medical International Huff cough simulation device
DE202017007467U1 (en) 2016-02-11 2021-12-08 Juul Labs, Inc. Fillable vaporizer cartridge
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
CN109152892B (en) 2016-05-19 2021-07-27 特鲁德尔医学国际公司 Intelligent holding chamber with valve
GB201609168D0 (en) 2016-05-25 2016-07-06 3M Innovative Properties Co Exhaust valve shroud for a personal protection respiratory device
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
US10786638B2 (en) 2016-07-08 2020-09-29 Trudell Medical International Nebulizer apparatus and method
WO2018007997A1 (en) 2016-07-08 2018-01-11 Trudell Medical International Smart oscillating positive expiratory pressure device
US11529224B2 (en) * 2016-10-05 2022-12-20 Pulmonx Corporation High resistance implanted bronchial isolation devices and methods
US10758333B2 (en) * 2016-10-05 2020-09-01 Pulmonx Corporation High resistance implanted bronchial isolation devices and methods
JP7093353B2 (en) 2016-12-09 2022-06-29 トゥルーデル メディカル インターナショナル Smart nebulizer
USD835260S1 (en) * 2017-04-06 2018-12-04 Abithas, Llc Delivery assist device for metered dose inhaler
US11559723B2 (en) 2017-05-03 2023-01-24 Trudell Medical International Combined oscillating positive expiratory pressure therapy and Huff Cough simulation device
US11439869B2 (en) 2017-05-19 2022-09-13 Trudell Medical International Positive expiratory pressure device
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
USD827808S1 (en) * 2017-09-29 2018-09-04 Jinfang Xiao Intubate laryngeal mask
WO2019070804A1 (en) * 2017-10-03 2019-04-11 Yasi's, Llc Respiratory therapy
WO2019110099A1 (en) 2017-12-06 2019-06-13 Qrumpharma Inc. Inhalable clofazimine formulation
AU2019205865A1 (en) 2018-01-04 2020-07-16 Trudell Medical International Smart oscillating positive expiratory pressure device
US10953278B2 (en) 2018-02-02 2021-03-23 Trudell Medical International Oscillating positive expiratory pressure device
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
EP3801714A4 (en) 2018-06-04 2022-03-09 Trudell Medical International Smart valved holding chamber
EP3840737A1 (en) 2018-08-23 2021-06-30 MannKind Corporation Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
JP2022512208A (en) 2018-12-13 2022-02-02 マンカインド コーポレイション Bedaquiline compositions, combinations containing them, methods for preparing them, methods of use and treatment containing them.
US10780318B1 (en) * 2019-04-18 2020-09-22 Firas Kasem Ghazzawi Breathing device with exhale and inhale valve to create resistance
US10960172B2 (en) * 2019-05-03 2021-03-30 Compact Medical Solutions, Llc Bag and valve for advanced respiratory support
US11179529B2 (en) 2019-05-03 2021-11-23 Compact Medical Solutions Llc Bag and valve for advanced respiratory support
USD952857S1 (en) 2019-05-03 2022-05-24 Compact Medical Solutions, Llc Respiratory assisting device with an expandable bag
CN114126629A (en) 2019-06-04 2022-03-01 三十呼吸有限公司 Methods and compositions for generating nitric oxide and uses thereof for delivery of nitric oxide via the respiratory tract
CN114206325A (en) 2019-06-04 2022-03-18 三十控股有限公司 Methods and compositions for generating nitric oxide and uses thereof
WO2020252135A1 (en) * 2019-06-11 2020-12-17 Rowley Justin Nebulizer with flutter valve
JP2022547826A (en) 2019-08-27 2022-11-16 トゥルーデル メディカル インターナショナル Vibrating positive expiratory pressure device
WO2021214440A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
US20230172973A1 (en) 2020-04-23 2023-06-08 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
EP4157237A2 (en) 2020-06-01 2023-04-05 Advent Therapeutics Inc. Pharmaceutical compositions comprising insoluble active ingredients
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
US11420010B1 (en) 2021-10-01 2022-08-23 Compact Medical Inc. Bag and valve for advanced respiratory support

Citations (227)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393869A (en) 1888-12-04 Inhaler
US2535844A (en) 1946-08-01 1950-12-26 John H Emerson Aspirator for administering medicine
US2670739A (en) 1951-07-02 1954-03-02 Charles M Mcneill Inhaler
US2882026A (en) 1955-08-31 1959-04-14 Chemetron Corp Nebulizer
GB975754A (en) 1961-05-15 1964-11-18 Pfizer Ltd Medicament administering apparatus
GB1017032A (en) 1963-12-12 1966-01-12 Aerosmoke Ltd Aerosol compositions
US3236458A (en) 1962-02-23 1966-02-22 Ramis Jean Aerosol apparatus
US3269665A (en) 1964-11-02 1966-08-30 Ralph G Cheney Nebulizer
US3363833A (en) 1964-06-15 1968-01-16 Laerdal Asmund Sigurd Elastic bag for artificial respiration apparatus
US3556122A (en) 1964-06-15 1971-01-19 Laerdal A S Valve for artificial respiration apparatus
US3565071A (en) 1968-09-19 1971-02-23 Abbott Lab Self-regulating therapeutic inhaler
US3580249A (en) 1968-09-16 1971-05-25 Kentaro Takaoka Aerosol nebulizers
US3584621A (en) 1968-10-31 1971-06-15 Bird F M Respiratory apparatus
US3630196A (en) 1969-08-22 1971-12-28 Bird F M Manual positive pressure breathing device
US3643686A (en) 1970-10-21 1972-02-22 Ewald Koegel High-velocity breathing valve
US3658059A (en) 1968-12-11 1972-04-25 Ritzau Pari Werk Kg Paul Inhaler
US3664337A (en) 1970-04-15 1972-05-23 Bio Logics Inc Respiration assembly and methods
US3809294A (en) 1973-06-27 1974-05-07 American Cyanamid Co Dispensing lung contacting powdered medicaments
US3809084A (en) 1970-02-16 1974-05-07 American Cyanamid Co Pressurized portable dispenser
US3826255A (en) 1972-06-22 1974-07-30 Hudson Oxygen Therapy Sales Co Intermittent positive pressure breathing manifold
US3838686A (en) 1971-10-14 1974-10-01 G Szekely Aerosol apparatus for inhalation therapy
US3874379A (en) 1973-08-15 1975-04-01 Becton Dickinson Co Manifold nebulizer system
US3897779A (en) 1973-06-27 1975-08-05 American Cyanamid Co Triamcinolone acetonide inhalation therapy
US3903884A (en) 1973-08-15 1975-09-09 Becton Dickinson Co Manifold nebulizer system
US3990442A (en) 1975-06-06 1976-11-09 Patneau Robert A Respiratory treatment device
US3994421A (en) 1975-09-29 1976-11-30 American Cyanamid Company Unitary therapeutic aerosol dispenser
US4093124A (en) 1976-07-26 1978-06-06 L'oreal Atomizer with air inlet valve
US4094317A (en) 1976-06-11 1978-06-13 Wasnich Richard D Nebulization system
US4106503A (en) 1977-03-11 1978-08-15 Richard R. Rosenthal Metering system for stimulating bronchial spasm
US4116387A (en) 1976-05-11 1978-09-26 Eastfield Corporation Mist generator
GB2000555A (en) 1977-07-01 1979-01-10 Ici Ltd Aerosol dispensing device
US4150071A (en) 1977-08-26 1979-04-17 Respiratory Care, Inc. Nebulizer
US4174712A (en) 1976-11-09 1979-11-20 Aktiebolaget Draco Device for use with medicinal inhalation devices
US4182366A (en) 1976-01-08 1980-01-08 Boehringer John R Positive end expiratory pressure device
JPS5540595A (en) 1978-09-11 1980-03-22 Newhouse Michael T Medicine inhaler
US4198969A (en) 1978-10-06 1980-04-22 Baxter Travenol Laboratories, Inc. Suction-operated nebulizer
US4231375A (en) 1977-10-20 1980-11-04 Boehringer John R Pulmonary exerciser
US4251033A (en) 1978-06-12 1981-02-17 Eastfield Corporation Mist generating structure and molding apparatus therefor
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4267832A (en) 1978-04-18 1981-05-19 Haekkinen Taisto Expiration valve apparatus for use with a respirator or like apparatus
US4275722A (en) 1979-05-04 1981-06-30 Sorensen Harry D Respiratory exerciser and rebreathing device
US4292966A (en) 1979-02-16 1981-10-06 Aktiebolaget Draco Aerosol inhalation device
US4298023A (en) 1980-09-09 1981-11-03 Mcginnis Gerald E Spring loaded exhalation valve
US4333450A (en) 1976-12-14 1982-06-08 Lester Victor E Nebulizer-manifold
US4344573A (en) 1979-06-08 1982-08-17 Hoechst Aktiengesellschaft Spray applicator
US4413784A (en) 1981-10-02 1983-11-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Constant-output atomizer
US4429835A (en) 1980-11-17 1984-02-07 Inge Brugger Spray-diffuser
US4470412A (en) 1982-03-19 1984-09-11 Trutek Research, Inc. Inhalation valve
US4496086A (en) 1981-05-14 1985-01-29 Pari-Symac Devices which comprise a helical spring used as conveying, extracting, quantity-controlling or mixing means
EP0134847A1 (en) 1983-08-02 1985-03-27 Trutek Research Inc. Inhalation valve
US4508118A (en) 1983-05-04 1985-04-02 Under Sea Industries, Inc. Diaphragm assembly for scuba diving regulator
US4509688A (en) 1981-12-04 1985-04-09 Puritan-Bennett Corporation One-piece nebulizer jet
US4509515A (en) 1982-02-23 1985-04-09 Fisons Plc Inhalation device
US4588129A (en) 1983-09-06 1986-05-13 Hudson Oxygen Therapy Sales Company Nebulizer
US4620670A (en) 1983-11-28 1986-11-04 Vortran Corporation Gas-powered nebulizer
US4635631A (en) 1983-11-04 1987-01-13 Sharp Kabushiki Kaisha Artificial respiration ventilator of air constant flow
US4637528A (en) 1984-01-19 1987-01-20 William H. Rorer, Inc. Articulated joint in aerosol medicament dispenser
US4641644A (en) 1981-09-15 1987-02-10 Aktiebolaget Draco Aerosol inhalation device
US4646644A (en) 1984-04-09 1987-03-03 Sanders Associates, Inc. Pneumatic time delay valve
US4657007A (en) 1982-06-28 1987-04-14 Whittaker General Medical Corporation Nebulizer
US4674491A (en) 1984-08-09 1987-06-23 Inge Brugger Inhaler
US4770413A (en) 1987-04-27 1988-09-13 Mba Healthcare Products, Inc. Breathing exercise device
US4796614A (en) 1987-02-26 1989-01-10 Trutek Research, Inc. Collapsible inhalation valve
US4834083A (en) 1988-05-12 1989-05-30 Minnesota Mining And Manufacturing Company Aerosol device
US4846168A (en) 1986-12-05 1989-07-11 Mect Corporation Inhaler
US4852561A (en) 1988-07-27 1989-08-01 Sperry C R Inhalation device
US4886057A (en) 1987-11-30 1989-12-12 E Z Breathe, Inc. Assisted breathing interface device
US4907583A (en) 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
EP0372148A1 (en) 1988-12-09 1990-06-13 Erik Folke Norell Lung exercising device
US4940051A (en) 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
US4981295A (en) 1987-05-11 1991-01-01 City Of Hope Respiratory training using feedback
WO1991000117A1 (en) 1989-07-05 1991-01-10 Fisons Plc Aerosol holding chamber
US5012803A (en) 1989-03-06 1991-05-07 Trudell Medical Modular medication inhaler
US5012804A (en) 1989-03-06 1991-05-07 Trudell Medical Medication inhaler with adult mask
EP0289563B1 (en) 1986-11-06 1991-05-29 Huhtamäki Oy Inhalation device
US5033463A (en) 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5040527A (en) 1990-12-18 1991-08-20 Healthscan Products Inc. Metered dose inhalation unit with slide means
US5042467A (en) 1990-03-28 1991-08-27 Trudell Medical Medication inhaler with fitting having a sonic signalling device
US5048729A (en) 1989-08-03 1991-09-17 United Kingdom Atomic Energy Authority Aerosol dispenser with flow diverter
US5109840A (en) 1991-02-14 1992-05-05 Specialty Packaging Licensing Company Resuscitator having directional control valve with internal "PEEP" adjustment valve
EP0514085A1 (en) 1991-05-14 1992-11-19 Scott Dibben Pty Limited Aerosol inhalation device
WO1992020391A1 (en) 1991-05-21 1992-11-26 Abbott Laboratories Aerosol inhalation device
CA2072544A1 (en) 1991-06-28 1992-12-29 Terence E. Weston Atomizing nozzle
US5178138A (en) 1990-09-11 1993-01-12 Walstrom Dennis R Drug delivery device
US5193529A (en) 1989-08-03 1993-03-16 Emmanuel Labaere Applicance for use in inspiration and expiration techniques and exercises
WO1993011817A1 (en) 1991-12-16 1993-06-24 The University Of Melbourne Improvements in the administration of aerosol compounds
JPH0548152U (en) 1991-11-28 1993-06-25 東京瓦斯株式会社 Reset device for fluidic gas meter
US5241954A (en) 1991-05-24 1993-09-07 Glenn Joseph G Nebulizer
US5250287A (en) 1991-06-14 1993-10-05 Miat S.P.A. Multi-dose insufflator for medicaments in powder form
US5280784A (en) 1990-09-19 1994-01-25 Paul Ritzau Pari-Werk Gmbh Device in particular and inhalating device for treating the lung and the respiratory tracts
US5297543A (en) 1992-06-24 1994-03-29 Healthscan Products, Inc. Medication inhaler mixer
EP0347779B1 (en) 1988-06-22 1994-05-04 CHIESI FARMACEUTICI S.p.A. A device for dispensing metered amounts of aerosol for inhalation
US5309900A (en) 1991-03-21 1994-05-10 Paul Ritzau Pari-Werk Gmbh Atomizer particularly for use in devices for inhalation therapy
US5312049A (en) 1992-07-16 1994-05-17 Bayler Howard O Improved valve mechanism for a nozzle
US5312046A (en) 1991-11-07 1994-05-17 Paul Ritzau Pari Werk Gmbh Liquid atomizer
EP0475257B1 (en) 1990-09-13 1994-06-22 CHIESI FARMACEUTICI S.p.A. Device for mouth-inhaling aerosol medicaments
US5357951A (en) 1993-06-02 1994-10-25 Mercury Enterprises, Inc Cardiac pulmonary resuscitator apparatus valve with integral air sampling port
USD355029S (en) 1993-01-21 1995-01-31 Boehringer Ingelheim International Gmbh Inhaler
US5427089A (en) 1989-04-17 1995-06-27 Glaxo Group Limited Valved auxiliary device for use with aerosol container
WO1995020414A1 (en) 1994-01-27 1995-08-03 Astra Aktiebolag An inhalation chamber for children for use in conjunction with a metered dose inhaler
US5456249A (en) 1991-10-15 1995-10-10 Kirk; Gilbert M. Resuscitator with carbon dioxide detector
US5458136A (en) 1993-03-31 1995-10-17 Paul Ritzau Pari-Werk Gmbh Assembly for producing aerosol pulses
US5461695A (en) 1992-08-05 1995-10-24 Paul Ritzau Pari-Werk Gmbh Nebulizing assembly with heating equipment
EP0678306A2 (en) 1994-04-20 1995-10-25 Diemolding Corporation Positive expiratory pressure device
US5477849A (en) 1994-05-31 1995-12-26 Fry; Stephen Spacer for medication inhaler
US5479920A (en) 1994-03-01 1996-01-02 Vortran Medical Technology, Inc. Breath actuated medicinal aerosol delivery apparatus
US5497765A (en) 1994-05-26 1996-03-12 Rd-Chus Inc. Device for the simultaneous delivery of beta-2 agonists and oxygen to a patient
US5497872A (en) 1994-07-01 1996-03-12 Pari Industries Method and apparatus for cleaning conveyor belts
US5501214A (en) 1994-09-26 1996-03-26 Respironics, Inc. Non-rebreathing valve and valve element therefor
US5505194A (en) 1994-03-23 1996-04-09 Abbott Laboratories Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
EP0548152B1 (en) 1990-09-12 1996-07-24 BISGAARD, Hans An inhaling device
US5549102A (en) 1991-11-07 1996-08-27 Paul Ritzau Pari-Werk Gmbh Nebulizer, especially for application in devices for inhalation therapy
US5562093A (en) 1995-09-06 1996-10-08 Gerson; Howard J. Mouth-to-mouth resuscitation barrier
GB2299512A (en) 1995-04-06 1996-10-09 Ian James Sharp Inhaler
WO1996032149A1 (en) 1995-04-14 1996-10-17 Inhale Therapeutic Systems Pulmonary delivery of aerosolized medicaments
US5570682A (en) 1993-12-14 1996-11-05 Ethex International, Inc. Passive inspiratory nebulizer system
US5575282A (en) 1991-02-22 1996-11-19 Paul Ritzau Pari-Werk Gmbh Oxygen distributor with both mouth and nose delivery ports
US5584285A (en) 1995-06-07 1996-12-17 Salter Labs Breathing circuit apparatus for a nebulizer
WO1997001365A1 (en) 1995-06-29 1997-01-16 Fisons Plc Inhalation device and method
US5596982A (en) 1994-05-19 1997-01-28 Paul Ritzau Pari-Werk Gmbh Apparatus for drying and buffering aerosols
US5613489A (en) 1994-12-07 1997-03-25 Westmed, Inc. Patient respiratory system drug applicator
US5617844A (en) 1995-09-21 1997-04-08 King; Russell W. Aerosol medication delivery system
US5622162A (en) 1991-03-05 1997-04-22 Aradigm Corporation Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval
US5629032A (en) 1995-08-25 1997-05-13 Pari Industries, Inc. Blow-molding apparatus
US5630409A (en) 1995-03-22 1997-05-20 Bono; Michael Nebulizer and inhalation device containing same
US5645049A (en) 1992-11-09 1997-07-08 Trudell Medical Limited Exhalation valve for face mask with spacer chamber connection
US5647345A (en) 1992-05-12 1997-07-15 Saul; Gilbert D. Respiratory stimulator & methods of use
US5658221A (en) 1995-02-10 1997-08-19 Hougen; Everett D. Portable personal breathing apparatus and method of using same
US5657853A (en) 1994-08-29 1997-08-19 Pari Industries, Inc. Belt conveyors having cleaning rollers
WO1997031668A1 (en) 1996-02-29 1997-09-04 Norton Healthcare Limited Power spacer
US5676130A (en) 1992-03-19 1997-10-14 Boehringer Ingelheim Gmbh, Inc. Separator for powdered inhalers
US5687912A (en) 1994-11-11 1997-11-18 Medic-Aid Limited Atomizer
US5701886A (en) 1995-08-07 1997-12-30 Ryatt; Sadie Treatment non-rebreather assembly and method for delivering oxygen and medication
EP0820780A1 (en) 1996-07-23 1998-01-28 Pedrali, Frank Vaporisation process and inhalation apparatus using the same
US5724962A (en) 1992-10-15 1998-03-10 Orion-Yhtyma Oy Valve for use in connection with an inhaler apparatus
US5724959A (en) 1990-10-02 1998-03-10 Aea Technology Plc Powder inhaler with specific orifice and baffle arrangement
US5738087A (en) 1995-09-21 1998-04-14 King; Russell W. Aerosol medication delivery system
US5740966A (en) 1993-12-17 1998-04-21 Paul Ritzau Pari-Werk Gmbh Nebulizer nozzle
US5752505A (en) 1996-03-21 1998-05-19 Unisia Jecs Corporation Inhalation-type medicine delivery device
US5765553A (en) 1996-11-27 1998-06-16 Diemolding Corporation Aerosol medication delivery facemask adapter
WO1998026827A1 (en) 1996-12-18 1998-06-25 Innovata Biomed Limited Powder inhaler
US5775320A (en) 1991-07-02 1998-07-07 Inhale Therapeutic Systems Method and device for delivering aerosolized medicaments
US5792057A (en) 1993-05-21 1998-08-11 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5803078A (en) 1994-05-06 1998-09-08 Brauner; Mark E. Methods and apparatus for intrapulmonary therapy and drug administration
US5816240A (en) 1995-07-14 1998-10-06 Techbase Pty. Ltd. Spacer
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US5840279A (en) 1995-06-21 1998-11-24 Asta Medica Aktiengesellschaft Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
US5848588A (en) 1994-05-25 1998-12-15 Trudell Medical Group Backpiece for receiving an MDI adapter in an aerosolization spacer
US5855202A (en) 1997-10-08 1999-01-05 Andrade; Joseph R. Aerosol holding chamber for a metered-dose inhaler
US5875774A (en) 1996-01-05 1999-03-02 Sunrise Medical Hhg Inc. Nebulizer
US5881718A (en) 1994-04-11 1999-03-16 Astra Aktiebolag Valve
US5890998A (en) 1995-02-10 1999-04-06 Hougen; Everett Douglas Portable personal breathing apparatus
WO1999016490A1 (en) 1997-09-26 1999-04-08 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US5896857A (en) 1996-12-20 1999-04-27 Resmed Limited Valve for use in a gas delivery system
US5899832A (en) 1996-06-14 1999-05-04 Hougen; Everett D. Compact lung exercising device
US5925831A (en) 1997-10-18 1999-07-20 Cardiopulmonary Technologies, Inc. Respiratory air flow sensor
EP0938908A2 (en) 1998-02-27 1999-09-01 Diemolding Corporation Metered dose inhaler cloud chamber
US5957389A (en) 1996-01-25 1999-09-28 Paul Ritzau Pari-Werk Gmbh Nebuliser
US6000394A (en) 1994-10-26 1999-12-14 Paul Rizau Pari-Werk Gmbh Generation of an aerosol of an exact dose
US6026808A (en) 1997-10-17 2000-02-22 Sheffield Pharmaceuticals, Inc. Methods and apparatus for delivering aerosolized medication
US6026809A (en) 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US6039042A (en) 1998-02-23 2000-03-21 Thayer Medical Corporation Portable chamber for metered dose inhaler dispensers
US6044859A (en) 1997-03-03 2000-04-04 Filtertek Inc Valve apparatus and method
US6044841A (en) 1997-08-29 2000-04-04 1263152 Ontario Inc. Breath actuated nebulizer with valve assembly having a relief piston
WO2000027455A1 (en) 1998-11-06 2000-05-18 Salter Labs Nebulizer mouthpiece and accessories
US6085741A (en) 1995-06-06 2000-07-11 Pari Gmbh Spezialisten Fur Effektive Inhalation Device for atomisation of fluids
US6102036A (en) 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6106479A (en) 1997-04-02 2000-08-22 Pari Gmbh Spezialisten Fur Effektive Inhalation Breath simulator
US6116233A (en) 1992-09-11 2000-09-12 Medic-Aid Limited Drug delivery arrangement
US6123075A (en) 1991-10-15 2000-09-26 Mallinckrodt, Inc. Resuscitator regulator with carbon dioxide detector
US6129080A (en) 1997-01-27 2000-10-10 Medic-Aid Limited Atomizer
WO2000059565A1 (en) 1999-04-07 2000-10-12 Trudell Medical International Aerosol medication delivery apparatus and system
US6131568A (en) 1998-02-26 2000-10-17 Medic-Aid Limited Nebulizer
US6176237B1 (en) 1997-08-06 2001-01-23 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy unit with a valve for limiting the inspiration flow
US6179164B1 (en) 1998-04-18 2001-01-30 Ing. Erich Pfeiffer Gmbh Dispenser for media, particularly powder
US6223745B1 (en) 1996-10-16 2001-05-01 Aga Aktiebolag Method and a device for producing a fine homogeneous aerosol
US6228346B1 (en) 1996-04-25 2001-05-08 Pari Gmbh Spezialisten Fur Effektive Inhalation Propellant mixtures and aerosols for micronizing medicaments with compressed gas
US6237589B1 (en) 1996-06-20 2001-05-29 Medic-Aid Limited Dispensing system
US6240917B1 (en) 1999-12-20 2001-06-05 Joseph R. Andrade Aerosol holding chamber for a metered-dose inhaler
US6257231B1 (en) 1998-12-03 2001-07-10 Ferraris Medical, Inc. Aerosol enhancement
US20010013341A1 (en) 1999-12-22 2001-08-16 Thomas Gallem Inhalation atomizer with a one -piece valve element
WO2001076671A2 (en) 2000-04-11 2001-10-18 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
US20010032643A1 (en) 1998-10-17 2001-10-25 Dieter Hochrainer Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
US20010054421A1 (en) 1998-10-02 2001-12-27 Pari Spezialisten Fur Effektive Inhalation Apparatus and method for generating an aerosol of an exact dose for inhalation purposes
US20020005196A1 (en) 1994-11-15 2002-01-17 Pari Gmbh Spezialisten Fur Effektive Inhalation Portable inhalator compressor device
WO2002005630A2 (en) 2000-07-14 2002-01-24 Tufts University Drug delivery device for animals
US20020020762A1 (en) 2000-07-28 2002-02-21 Titus Selzer Liquid atomizer device
US6367471B1 (en) 1999-11-01 2002-04-09 Sheffield Pharmaceuticals, Inc. Internal vortex mechanism for inhaler device
US20020056448A1 (en) 1998-01-16 2002-05-16 Kevin Stapleton Mouth piece for inhalation therapy units
US6412481B1 (en) 1999-12-23 2002-07-02 Robert Bienvenu Sealed backpressure attachment device for nebulizer
US6464388B2 (en) 2000-11-03 2002-10-15 Pari Mixer incorporating imbalance
US20020157663A1 (en) 2001-03-20 2002-10-31 Rick Blacker Nebulizer apparatus and method
US6481438B1 (en) 1998-10-08 2002-11-19 Pari Gmbh Spezialisten Fur Effetive Inhalation Meter
US6514177B1 (en) 1995-05-30 2003-02-04 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhaling apparatus compressor with improved diaphragm assembly
US6513727B1 (en) 1998-06-18 2003-02-04 Pari Gmbh Spezialisten Fureffektive Inhalation Liquid atomizer device
US20030037785A1 (en) 2001-06-01 2003-02-27 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy apparatus having a valve for limiting the inspiration flow
US20030037788A1 (en) 2001-06-01 2003-02-27 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation mask
US6543448B1 (en) 1994-09-21 2003-04-08 Inhale Therapeutic Systems, Inc. Apparatus and methods for dispersing dry powder medicaments
US6581598B1 (en) 1999-11-24 2003-06-24 Dhd Healthcare Corporation Positive expiratory pressure device
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
US6595203B1 (en) 2000-11-28 2003-07-22 Forrest M. Bird Apparatus for administering intermittent percussive ventilation and unitary breathing head assembly for use therein
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
EP1358901A2 (en) 2002-05-02 2003-11-05 PARI Innovative Manufactures Inc. Aerosol medication inhalation system
USD483860S1 (en) 2002-11-12 2003-12-16 Pari Gmbh Spezialisten Fur Effektive Inhalation Electronic inhaler and control unit
US6679252B2 (en) 1998-02-23 2004-01-20 Thayer Medical Corporation Collapsible, disposable MDI spacer and method
US20040089295A1 (en) 2001-01-23 2004-05-13 Thomas Gallem Aerosol generator
US20040094148A1 (en) 1998-12-09 2004-05-20 Amar Lulla Spacer device for inhaler
US6752145B1 (en) 1999-05-18 2004-06-22 Smithkline Beecham Corporation Medication dispenser
US20040250816A1 (en) 2003-05-19 2004-12-16 Pari Gmbh Spezialisten Fur Effective Inhalation Inhalation therapy mask and device for animals
US20050056274A1 (en) 2001-10-18 2005-03-17 Pari Gmbh Spezialisten Fur Effektive Device for inhalation therapy
US20050224076A1 (en) 2004-04-07 2005-10-13 Pari Gmbh Spezialisten Fur Effektive Inhalation Aerosol generation device and inhalation device therewith
US20050244339A1 (en) 2003-10-15 2005-11-03 Pari Gmbh Pharmaceutical aerosol composition
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US20060048772A1 (en) 2004-08-27 2006-03-09 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US20060057073A1 (en) 2002-11-08 2006-03-16 Pari Gmbh Wet granulation process
US7013896B2 (en) 2001-05-08 2006-03-21 Trudell Medical International Mask with inhalation valve
US20060065267A1 (en) 2004-03-18 2006-03-30 Pari Innovative Manufacturers, Inc. Breath enhanced nebulizer with interchangeable top portions
US20060102172A1 (en) 2002-10-30 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US20060102178A1 (en) 2002-06-13 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Device for recording the parameters of an aerosol in particular in inhalation therapy devices
US7051731B1 (en) 2002-11-15 2006-05-30 Rogerson L Keith Oxygen delivery system
US7059320B2 (en) 2001-10-18 2006-06-13 Pari Gmbh Spezialstein Fur Effektive Inhalation Inhalation therapy apparatus
US20060162723A1 (en) 2002-07-03 2006-07-27 Pari Gmbh Spezialisten Fur Effektive Inhalation therapy device
US20060207591A1 (en) 2005-02-11 2006-09-21 Pari Gmbh Spezialisten Fuer Effektive Inhalation Aerosol generating means for inhalation therapy devices
US20060213503A1 (en) 2005-02-07 2006-09-28 Pari Gmbh Spezialisten Fuer Effektive Inhalation Inhalation therapy device that can be actuated in different modes
US20060254578A1 (en) 2005-05-13 2006-11-16 Pari Gmbh Spezialisten Fuer Effektive Inhalation Inhalation therapy device with a nebulising nozzle and a compressor
US20060289002A1 (en) 2005-06-24 2006-12-28 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US7261102B2 (en) 2001-09-12 2007-08-28 Norton Healthcare Ltd. Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540595Y2 (en) 1974-01-31 1980-09-22

Patent Citations (267)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393869A (en) 1888-12-04 Inhaler
US2535844A (en) 1946-08-01 1950-12-26 John H Emerson Aspirator for administering medicine
US2670739A (en) 1951-07-02 1954-03-02 Charles M Mcneill Inhaler
US2882026A (en) 1955-08-31 1959-04-14 Chemetron Corp Nebulizer
GB975754A (en) 1961-05-15 1964-11-18 Pfizer Ltd Medicament administering apparatus
US3236458A (en) 1962-02-23 1966-02-22 Ramis Jean Aerosol apparatus
GB1017032A (en) 1963-12-12 1966-01-12 Aerosmoke Ltd Aerosol compositions
US3363833A (en) 1964-06-15 1968-01-16 Laerdal Asmund Sigurd Elastic bag for artificial respiration apparatus
US3556122A (en) 1964-06-15 1971-01-19 Laerdal A S Valve for artificial respiration apparatus
US3269665A (en) 1964-11-02 1966-08-30 Ralph G Cheney Nebulizer
US3580249A (en) 1968-09-16 1971-05-25 Kentaro Takaoka Aerosol nebulizers
US3565071A (en) 1968-09-19 1971-02-23 Abbott Lab Self-regulating therapeutic inhaler
US3584621A (en) 1968-10-31 1971-06-15 Bird F M Respiratory apparatus
US3658059A (en) 1968-12-11 1972-04-25 Ritzau Pari Werk Kg Paul Inhaler
US3630196A (en) 1969-08-22 1971-12-28 Bird F M Manual positive pressure breathing device
US3809084A (en) 1970-02-16 1974-05-07 American Cyanamid Co Pressurized portable dispenser
US3664337A (en) 1970-04-15 1972-05-23 Bio Logics Inc Respiration assembly and methods
US3643686A (en) 1970-10-21 1972-02-22 Ewald Koegel High-velocity breathing valve
US3838686A (en) 1971-10-14 1974-10-01 G Szekely Aerosol apparatus for inhalation therapy
US3826255A (en) 1972-06-22 1974-07-30 Hudson Oxygen Therapy Sales Co Intermittent positive pressure breathing manifold
US3809294A (en) 1973-06-27 1974-05-07 American Cyanamid Co Dispensing lung contacting powdered medicaments
US3897779A (en) 1973-06-27 1975-08-05 American Cyanamid Co Triamcinolone acetonide inhalation therapy
US3874379A (en) 1973-08-15 1975-04-01 Becton Dickinson Co Manifold nebulizer system
US3903884A (en) 1973-08-15 1975-09-09 Becton Dickinson Co Manifold nebulizer system
US3990442A (en) 1975-06-06 1976-11-09 Patneau Robert A Respiratory treatment device
US3994421A (en) 1975-09-29 1976-11-30 American Cyanamid Company Unitary therapeutic aerosol dispenser
US4182366A (en) 1976-01-08 1980-01-08 Boehringer John R Positive end expiratory pressure device
US4116387A (en) 1976-05-11 1978-09-26 Eastfield Corporation Mist generator
US4094317A (en) 1976-06-11 1978-06-13 Wasnich Richard D Nebulization system
US4093124A (en) 1976-07-26 1978-06-06 L'oreal Atomizer with air inlet valve
US4174712A (en) 1976-11-09 1979-11-20 Aktiebolaget Draco Device for use with medicinal inhalation devices
US4333450A (en) 1976-12-14 1982-06-08 Lester Victor E Nebulizer-manifold
US4106503A (en) 1977-03-11 1978-08-15 Richard R. Rosenthal Metering system for stimulating bronchial spasm
GB2000555A (en) 1977-07-01 1979-01-10 Ici Ltd Aerosol dispensing device
US4150071A (en) 1977-08-26 1979-04-17 Respiratory Care, Inc. Nebulizer
US4231375A (en) 1977-10-20 1980-11-04 Boehringer John R Pulmonary exerciser
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4267832A (en) 1978-04-18 1981-05-19 Haekkinen Taisto Expiration valve apparatus for use with a respirator or like apparatus
US4251033A (en) 1978-06-12 1981-02-17 Eastfield Corporation Mist generating structure and molding apparatus therefor
EP0009667A1 (en) 1978-09-11 1980-04-16 Michael T. Dr. Newhouse Inhalation device
JPS5540595A (en) 1978-09-11 1980-03-22 Newhouse Michael T Medicine inhaler
US4198969A (en) 1978-10-06 1980-04-22 Baxter Travenol Laboratories, Inc. Suction-operated nebulizer
EP0015247B1 (en) 1979-02-16 1982-12-22 Aktiebolaget DRACO An aerosol inhalation device
US4292966A (en) 1979-02-16 1981-10-06 Aktiebolaget Draco Aerosol inhalation device
US4275722A (en) 1979-05-04 1981-06-30 Sorensen Harry D Respiratory exerciser and rebreathing device
US4344573A (en) 1979-06-08 1982-08-17 Hoechst Aktiengesellschaft Spray applicator
US4298023A (en) 1980-09-09 1981-11-03 Mcginnis Gerald E Spring loaded exhalation valve
US4429835A (en) 1980-11-17 1984-02-07 Inge Brugger Spray-diffuser
US4496086A (en) 1981-05-14 1985-01-29 Pari-Symac Devices which comprise a helical spring used as conveying, extracting, quantity-controlling or mixing means
US4641644A (en) 1981-09-15 1987-02-10 Aktiebolaget Draco Aerosol inhalation device
US4413784A (en) 1981-10-02 1983-11-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Constant-output atomizer
US4509688A (en) 1981-12-04 1985-04-09 Puritan-Bennett Corporation One-piece nebulizer jet
US4509515A (en) 1982-02-23 1985-04-09 Fisons Plc Inhalation device
US4470412A (en) 1982-03-19 1984-09-11 Trutek Research, Inc. Inhalation valve
US4657007A (en) 1982-06-28 1987-04-14 Whittaker General Medical Corporation Nebulizer
US4508118A (en) 1983-05-04 1985-04-02 Under Sea Industries, Inc. Diaphragm assembly for scuba diving regulator
EP0134847A1 (en) 1983-08-02 1985-03-27 Trutek Research Inc. Inhalation valve
US4588129A (en) 1983-09-06 1986-05-13 Hudson Oxygen Therapy Sales Company Nebulizer
US4635631A (en) 1983-11-04 1987-01-13 Sharp Kabushiki Kaisha Artificial respiration ventilator of air constant flow
US4620670A (en) 1983-11-28 1986-11-04 Vortran Corporation Gas-powered nebulizer
US4940051A (en) 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
US4637528A (en) 1984-01-19 1987-01-20 William H. Rorer, Inc. Articulated joint in aerosol medicament dispenser
US4646644A (en) 1984-04-09 1987-03-03 Sanders Associates, Inc. Pneumatic time delay valve
US4674491A (en) 1984-08-09 1987-06-23 Inge Brugger Inhaler
US4907583A (en) 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
EP0289563B1 (en) 1986-11-06 1991-05-29 Huhtamäki Oy Inhalation device
US4846168A (en) 1986-12-05 1989-07-11 Mect Corporation Inhaler
US4796614A (en) 1987-02-26 1989-01-10 Trutek Research, Inc. Collapsible inhalation valve
US4770413A (en) 1987-04-27 1988-09-13 Mba Healthcare Products, Inc. Breathing exercise device
US4981295A (en) 1987-05-11 1991-01-01 City Of Hope Respiratory training using feedback
US4886057A (en) 1987-11-30 1989-12-12 E Z Breathe, Inc. Assisted breathing interface device
US4834083A (en) 1988-05-12 1989-05-30 Minnesota Mining And Manufacturing Company Aerosol device
EP0347779B1 (en) 1988-06-22 1994-05-04 CHIESI FARMACEUTICI S.p.A. A device for dispensing metered amounts of aerosol for inhalation
US4852561A (en) 1988-07-27 1989-08-01 Sperry C R Inhalation device
EP0372148A1 (en) 1988-12-09 1990-06-13 Erik Folke Norell Lung exercising device
US5012803A (en) 1989-03-06 1991-05-07 Trudell Medical Modular medication inhaler
US5012804A (en) 1989-03-06 1991-05-07 Trudell Medical Medication inhaler with adult mask
US5427089A (en) 1989-04-17 1995-06-27 Glaxo Group Limited Valved auxiliary device for use with aerosol container
WO1991000117A1 (en) 1989-07-05 1991-01-10 Fisons Plc Aerosol holding chamber
US5048729A (en) 1989-08-03 1991-09-17 United Kingdom Atomic Energy Authority Aerosol dispenser with flow diverter
US5193529A (en) 1989-08-03 1993-03-16 Emmanuel Labaere Applicance for use in inspiration and expiration techniques and exercises
US5033463A (en) 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5042467A (en) 1990-03-28 1991-08-27 Trudell Medical Medication inhaler with fitting having a sonic signalling device
US5178138A (en) 1990-09-11 1993-01-12 Walstrom Dennis R Drug delivery device
EP0548152B1 (en) 1990-09-12 1996-07-24 BISGAARD, Hans An inhaling device
US5755221A (en) 1990-09-12 1998-05-26 Bisgaard; Hans Aerosol inhaler with piston dump
EP0475257B1 (en) 1990-09-13 1994-06-22 CHIESI FARMACEUTICI S.p.A. Device for mouth-inhaling aerosol medicaments
US5280784A (en) 1990-09-19 1994-01-25 Paul Ritzau Pari-Werk Gmbh Device in particular and inhalating device for treating the lung and the respiratory tracts
US5724959A (en) 1990-10-02 1998-03-10 Aea Technology Plc Powder inhaler with specific orifice and baffle arrangement
US5040527A (en) 1990-12-18 1991-08-20 Healthscan Products Inc. Metered dose inhalation unit with slide means
US5109840A (en) 1991-02-14 1992-05-05 Specialty Packaging Licensing Company Resuscitator having directional control valve with internal "PEEP" adjustment valve
US5575282A (en) 1991-02-22 1996-11-19 Paul Ritzau Pari-Werk Gmbh Oxygen distributor with both mouth and nose delivery ports
US5622162A (en) 1991-03-05 1997-04-22 Aradigm Corporation Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval
US5309900A (en) 1991-03-21 1994-05-10 Paul Ritzau Pari-Werk Gmbh Atomizer particularly for use in devices for inhalation therapy
US5385140A (en) 1991-05-14 1995-01-31 Lindrew Pty Limited Aerosol inhalation device
EP0514085B1 (en) 1991-05-14 1997-07-02 Scott Dibben Pty Limited Aerosol inhalation device
EP0514085A1 (en) 1991-05-14 1992-11-19 Scott Dibben Pty Limited Aerosol inhalation device
WO1992020391A1 (en) 1991-05-21 1992-11-26 Abbott Laboratories Aerosol inhalation device
EP0585379B1 (en) 1991-05-21 1998-09-30 Abbott Laboratories Aerosol inhalation device
US5241954A (en) 1991-05-24 1993-09-07 Glenn Joseph G Nebulizer
US5250287A (en) 1991-06-14 1993-10-05 Miat S.P.A. Multi-dose insufflator for medicaments in powder form
CA2072544A1 (en) 1991-06-28 1992-12-29 Terence E. Weston Atomizing nozzle
EP0520571B1 (en) 1991-06-28 1998-09-09 Weston Medical Limited Atomising nozzle
JPH06178954A (en) 1991-06-28 1994-06-28 Glaxo Group Ltd Spray nozzle
EP0520571A1 (en) 1991-06-28 1992-12-30 Glaxo Group Limited Atomising nozzle
US5775320A (en) 1991-07-02 1998-07-07 Inhale Therapeutic Systems Method and device for delivering aerosolized medicaments
US5456249A (en) 1991-10-15 1995-10-10 Kirk; Gilbert M. Resuscitator with carbon dioxide detector
US6123075A (en) 1991-10-15 2000-09-26 Mallinckrodt, Inc. Resuscitator regulator with carbon dioxide detector
US5312046A (en) 1991-11-07 1994-05-17 Paul Ritzau Pari Werk Gmbh Liquid atomizer
US5549102A (en) 1991-11-07 1996-08-27 Paul Ritzau Pari-Werk Gmbh Nebulizer, especially for application in devices for inhalation therapy
JPH0548152U (en) 1991-11-28 1993-06-25 東京瓦斯株式会社 Reset device for fluidic gas meter
WO1993011817A1 (en) 1991-12-16 1993-06-24 The University Of Melbourne Improvements in the administration of aerosol compounds
US5676130A (en) 1992-03-19 1997-10-14 Boehringer Ingelheim Gmbh, Inc. Separator for powdered inhalers
US5647345A (en) 1992-05-12 1997-07-15 Saul; Gilbert D. Respiratory stimulator & methods of use
US5297543A (en) 1992-06-24 1994-03-29 Healthscan Products, Inc. Medication inhaler mixer
US5312049A (en) 1992-07-16 1994-05-17 Bayler Howard O Improved valve mechanism for a nozzle
US5461695A (en) 1992-08-05 1995-10-24 Paul Ritzau Pari-Werk Gmbh Nebulizing assembly with heating equipment
US6116233A (en) 1992-09-11 2000-09-12 Medic-Aid Limited Drug delivery arrangement
US5724962A (en) 1992-10-15 1998-03-10 Orion-Yhtyma Oy Valve for use in connection with an inhaler apparatus
US5645049A (en) 1992-11-09 1997-07-08 Trudell Medical Limited Exhalation valve for face mask with spacer chamber connection
US5988160A (en) * 1992-11-09 1999-11-23 Trudell Medical Limited Exhalation valve for face mask with spacer chamber connection
USD355029S (en) 1993-01-21 1995-01-31 Boehringer Ingelheim International Gmbh Inhaler
US5458136A (en) 1993-03-31 1995-10-17 Paul Ritzau Pari-Werk Gmbh Assembly for producing aerosol pulses
US5792057A (en) 1993-05-21 1998-08-11 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5357951A (en) 1993-06-02 1994-10-25 Mercury Enterprises, Inc Cardiac pulmonary resuscitator apparatus valve with integral air sampling port
US5570682A (en) 1993-12-14 1996-11-05 Ethex International, Inc. Passive inspiratory nebulizer system
US5740966A (en) 1993-12-17 1998-04-21 Paul Ritzau Pari-Werk Gmbh Nebulizer nozzle
WO1995020414A1 (en) 1994-01-27 1995-08-03 Astra Aktiebolag An inhalation chamber for children for use in conjunction with a metered dose inhaler
US5479920A (en) 1994-03-01 1996-01-02 Vortran Medical Technology, Inc. Breath actuated medicinal aerosol delivery apparatus
US5505194A (en) 1994-03-23 1996-04-09 Abbott Laboratories Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
US5881718A (en) 1994-04-11 1999-03-16 Astra Aktiebolag Valve
US6102036A (en) 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US5598839A (en) 1994-04-20 1997-02-04 Diemolding Corporation Positive expiratory pressure device
EP0678306A2 (en) 1994-04-20 1995-10-25 Diemolding Corporation Positive expiratory pressure device
US5803078A (en) 1994-05-06 1998-09-08 Brauner; Mark E. Methods and apparatus for intrapulmonary therapy and drug administration
US5596982A (en) 1994-05-19 1997-01-28 Paul Ritzau Pari-Werk Gmbh Apparatus for drying and buffering aerosols
US5848588A (en) 1994-05-25 1998-12-15 Trudell Medical Group Backpiece for receiving an MDI adapter in an aerosolization spacer
US5497765A (en) 1994-05-26 1996-03-12 Rd-Chus Inc. Device for the simultaneous delivery of beta-2 agonists and oxygen to a patient
US5477849A (en) 1994-05-31 1995-12-26 Fry; Stephen Spacer for medication inhaler
US5497872A (en) 1994-07-01 1996-03-12 Pari Industries Method and apparatus for cleaning conveyor belts
US5657853A (en) 1994-08-29 1997-08-19 Pari Industries, Inc. Belt conveyors having cleaning rollers
US6543448B1 (en) 1994-09-21 2003-04-08 Inhale Therapeutic Systems, Inc. Apparatus and methods for dispersing dry powder medicaments
US5501214A (en) 1994-09-26 1996-03-26 Respironics, Inc. Non-rebreathing valve and valve element therefor
US6000394A (en) 1994-10-26 1999-12-14 Paul Rizau Pari-Werk Gmbh Generation of an aerosol of an exact dose
US5687912A (en) 1994-11-11 1997-11-18 Medic-Aid Limited Atomizer
US20020005196A1 (en) 1994-11-15 2002-01-17 Pari Gmbh Spezialisten Fur Effektive Inhalation Portable inhalator compressor device
US5613489A (en) 1994-12-07 1997-03-25 Westmed, Inc. Patient respiratory system drug applicator
US5890998A (en) 1995-02-10 1999-04-06 Hougen; Everett Douglas Portable personal breathing apparatus
US5658221A (en) 1995-02-10 1997-08-19 Hougen; Everett D. Portable personal breathing apparatus and method of using same
US5630409A (en) 1995-03-22 1997-05-20 Bono; Michael Nebulizer and inhalation device containing same
GB2299512A (en) 1995-04-06 1996-10-09 Ian James Sharp Inhaler
WO1996032149A1 (en) 1995-04-14 1996-10-17 Inhale Therapeutic Systems Pulmonary delivery of aerosolized medicaments
US6514177B1 (en) 1995-05-30 2003-02-04 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhaling apparatus compressor with improved diaphragm assembly
US6085741A (en) 1995-06-06 2000-07-11 Pari Gmbh Spezialisten Fur Effektive Inhalation Device for atomisation of fluids
US5584285A (en) 1995-06-07 1996-12-17 Salter Labs Breathing circuit apparatus for a nebulizer
US5840279A (en) 1995-06-21 1998-11-24 Asta Medica Aktiengesellschaft Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
WO1997001365A1 (en) 1995-06-29 1997-01-16 Fisons Plc Inhalation device and method
US6138673A (en) 1995-06-29 2000-10-31 Fisons Limited Inhalation device and method
US5816240A (en) 1995-07-14 1998-10-06 Techbase Pty. Ltd. Spacer
US5701886A (en) 1995-08-07 1997-12-30 Ryatt; Sadie Treatment non-rebreather assembly and method for delivering oxygen and medication
US5629032A (en) 1995-08-25 1997-05-13 Pari Industries, Inc. Blow-molding apparatus
US5562093A (en) 1995-09-06 1996-10-08 Gerson; Howard J. Mouth-to-mouth resuscitation barrier
US5738087A (en) 1995-09-21 1998-04-14 King; Russell W. Aerosol medication delivery system
US5617844A (en) 1995-09-21 1997-04-08 King; Russell W. Aerosol medication delivery system
US5875774A (en) 1996-01-05 1999-03-02 Sunrise Medical Hhg Inc. Nebulizer
US5957389A (en) 1996-01-25 1999-09-28 Paul Ritzau Pari-Werk Gmbh Nebuliser
US6026809A (en) 1996-01-25 2000-02-22 Microdose Technologies, Inc. Inhalation device
US7080643B2 (en) 1996-02-13 2006-07-25 Trudell Medical Internationl Nebulizer apparatus and method
US20030005929A1 (en) 1996-02-13 2003-01-09 1263152 Ontario Inc. Nebulizer apparatus and method
US20030015193A1 (en) 1996-02-13 2003-01-23 1263152 Ontario Inc. Nebulizer apparatus and method
US6612303B1 (en) 1996-02-13 2003-09-02 1263152 Ontario Inc. Nebulizer apparatus and method
US6644304B2 (en) 1996-02-13 2003-11-11 1263152 Ontario Inc. Nebulizer apparatus and method
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6748945B2 (en) 1996-02-13 2004-06-15 Trudell Medical International Nebulizer apparatus and method
WO1997031668A1 (en) 1996-02-29 1997-09-04 Norton Healthcare Limited Power spacer
US5752505A (en) 1996-03-21 1998-05-19 Unisia Jecs Corporation Inhalation-type medicine delivery device
US6228346B1 (en) 1996-04-25 2001-05-08 Pari Gmbh Spezialisten Fur Effektive Inhalation Propellant mixtures and aerosols for micronizing medicaments with compressed gas
US5899832A (en) 1996-06-14 1999-05-04 Hougen; Everett D. Compact lung exercising device
US6237589B1 (en) 1996-06-20 2001-05-29 Medic-Aid Limited Dispensing system
EP0820780A1 (en) 1996-07-23 1998-01-28 Pedrali, Frank Vaporisation process and inhalation apparatus using the same
US6223745B1 (en) 1996-10-16 2001-05-01 Aga Aktiebolag Method and a device for producing a fine homogeneous aerosol
US5765553A (en) 1996-11-27 1998-06-16 Diemolding Corporation Aerosol medication delivery facemask adapter
WO1998026827A1 (en) 1996-12-18 1998-06-25 Innovata Biomed Limited Powder inhaler
US5896857A (en) 1996-12-20 1999-04-27 Resmed Limited Valve for use in a gas delivery system
US6129080A (en) 1997-01-27 2000-10-10 Medic-Aid Limited Atomizer
US6044859A (en) 1997-03-03 2000-04-04 Filtertek Inc Valve apparatus and method
US6106479A (en) 1997-04-02 2000-08-22 Pari Gmbh Spezialisten Fur Effektive Inhalation Breath simulator
US6176237B1 (en) 1997-08-06 2001-01-23 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy unit with a valve for limiting the inspiration flow
US6044841A (en) 1997-08-29 2000-04-04 1263152 Ontario Inc. Breath actuated nebulizer with valve assembly having a relief piston
US6450163B1 (en) 1997-08-29 2002-09-17 Trudell Medical International Breath actuated nebulizer with valve assembly having a relief piston
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US6435177B1 (en) 1997-09-26 2002-08-20 Trudell Medical International Aerosol medication delivery apparatus and system
WO1999016490A1 (en) 1997-09-26 1999-04-08 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US6345617B1 (en) 1997-09-26 2002-02-12 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US5855202A (en) 1997-10-08 1999-01-05 Andrade; Joseph R. Aerosol holding chamber for a metered-dose inhaler
US6026808A (en) 1997-10-17 2000-02-22 Sheffield Pharmaceuticals, Inc. Methods and apparatus for delivering aerosolized medication
US5925831A (en) 1997-10-18 1999-07-20 Cardiopulmonary Technologies, Inc. Respiratory air flow sensor
US6089105A (en) 1997-10-18 2000-07-18 Cardiopulmonary Technologies, Inc. Tubing connector
US20020056448A1 (en) 1998-01-16 2002-05-16 Kevin Stapleton Mouth piece for inhalation therapy units
US6606990B2 (en) 1998-01-16 2003-08-19 Pari Gmbh Spezialisten Fur Effektive Inhalation Mouth piece for inhalation therapy units
US6039042A (en) 1998-02-23 2000-03-21 Thayer Medical Corporation Portable chamber for metered dose inhaler dispensers
US6679252B2 (en) 1998-02-23 2004-01-20 Thayer Medical Corporation Collapsible, disposable MDI spacer and method
US6131568A (en) 1998-02-26 2000-10-17 Medic-Aid Limited Nebulizer
US6026807A (en) 1998-02-27 2000-02-22 Diemolding Corporation Metered dose inhaler cloud chamber
EP0938908A2 (en) 1998-02-27 1999-09-01 Diemolding Corporation Metered dose inhaler cloud chamber
US6179164B1 (en) 1998-04-18 2001-01-30 Ing. Erich Pfeiffer Gmbh Dispenser for media, particularly powder
US6513727B1 (en) 1998-06-18 2003-02-04 Pari Gmbh Spezialisten Fureffektive Inhalation Liquid atomizer device
US20010054421A1 (en) 1998-10-02 2001-12-27 Pari Spezialisten Fur Effektive Inhalation Apparatus and method for generating an aerosol of an exact dose for inhalation purposes
US6481438B1 (en) 1998-10-08 2002-11-19 Pari Gmbh Spezialisten Fur Effetive Inhalation Meter
US6679251B1 (en) 1998-10-08 2004-01-20 Pari Gmbh Spezialisten Fur Effektive Inhalation Actuating device for meters and metering aerosol dispensing device with an actuating device for meters
US20010032643A1 (en) 1998-10-17 2001-10-25 Dieter Hochrainer Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
WO2000027455A1 (en) 1998-11-06 2000-05-18 Salter Labs Nebulizer mouthpiece and accessories
US6631721B1 (en) 1998-11-06 2003-10-14 Salter Labs Nebulizer mouthpiece and accessories
US6257231B1 (en) 1998-12-03 2001-07-10 Ferraris Medical, Inc. Aerosol enhancement
US20040094148A1 (en) 1998-12-09 2004-05-20 Amar Lulla Spacer device for inhaler
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
WO2000059565A1 (en) 1999-04-07 2000-10-12 Trudell Medical International Aerosol medication delivery apparatus and system
US6752145B1 (en) 1999-05-18 2004-06-22 Smithkline Beecham Corporation Medication dispenser
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US6367471B1 (en) 1999-11-01 2002-04-09 Sheffield Pharmaceuticals, Inc. Internal vortex mechanism for inhaler device
US20060054166A1 (en) 1999-11-05 2006-03-16 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation nebulizer
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US6581598B1 (en) 1999-11-24 2003-06-24 Dhd Healthcare Corporation Positive expiratory pressure device
US6240917B1 (en) 1999-12-20 2001-06-05 Joseph R. Andrade Aerosol holding chamber for a metered-dose inhaler
US20010013341A1 (en) 1999-12-22 2001-08-16 Thomas Gallem Inhalation atomizer with a one -piece valve element
US6513519B2 (en) 1999-12-22 2003-02-04 Pari Gmbh Spezialsten Fur Effective Inhalation Inhalation atomizer with a one-piece valve element
US6412481B1 (en) 1999-12-23 2002-07-02 Robert Bienvenu Sealed backpressure attachment device for nebulizer
WO2001076671A2 (en) 2000-04-11 2001-10-18 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
USRE43174E1 (en) * 2000-04-11 2012-02-14 Trudell Medical International Aerosol delivery apparatus
US6557549B2 (en) 2000-04-11 2003-05-06 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
US6848443B2 (en) 2000-04-11 2005-02-01 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
WO2002005630A2 (en) 2000-07-14 2002-01-24 Tufts University Drug delivery device for animals
US20020020762A1 (en) 2000-07-28 2002-02-21 Titus Selzer Liquid atomizer device
US6464388B2 (en) 2000-11-03 2002-10-15 Pari Mixer incorporating imbalance
US6595203B1 (en) 2000-11-28 2003-07-22 Forrest M. Bird Apparatus for administering intermittent percussive ventilation and unitary breathing head assembly for use therein
US20040089295A1 (en) 2001-01-23 2004-05-13 Thomas Gallem Aerosol generator
US6983747B2 (en) 2001-01-23 2006-01-10 Pari GmbH Spezialisten für effektive Inhalation Aerosol generator
US6929003B2 (en) 2001-03-20 2005-08-16 Trudell Medical International Nebulizer apparatus and method
US20020157663A1 (en) 2001-03-20 2002-10-31 Rick Blacker Nebulizer apparatus and method
US7013896B2 (en) 2001-05-08 2006-03-21 Trudell Medical International Mask with inhalation valve
US20030037785A1 (en) 2001-06-01 2003-02-27 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy apparatus having a valve for limiting the inspiration flow
US7131440B2 (en) 2001-06-01 2006-11-07 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy apparatus having a valve for limiting the inspiration flow
US20030037788A1 (en) 2001-06-01 2003-02-27 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation mask
US7261102B2 (en) 2001-09-12 2007-08-28 Norton Healthcare Ltd. Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule
US20050056274A1 (en) 2001-10-18 2005-03-17 Pari Gmbh Spezialisten Fur Effektive Device for inhalation therapy
US7059320B2 (en) 2001-10-18 2006-06-13 Pari Gmbh Spezialstein Fur Effektive Inhalation Inhalation therapy apparatus
US20060011196A2 (en) 2002-05-02 2006-01-19 Pari Innovative Manufacturers, Inc. Aerosol Medication Inhalation System
US20030205226A1 (en) 2002-05-02 2003-11-06 Pre Holding, Inc. Aerosol medication inhalation system
US7562656B2 (en) 2002-05-02 2009-07-21 Hydrate, Inc. Aerosol medication inhalation system
EP1358901A2 (en) 2002-05-02 2003-11-05 PARI Innovative Manufactures Inc. Aerosol medication inhalation system
US20050039741A1 (en) 2002-05-02 2005-02-24 Pari Innovative Manufacturers, Inc. Aerosol medication inhalation system
US20060102178A1 (en) 2002-06-13 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Device for recording the parameters of an aerosol in particular in inhalation therapy devices
US20060162723A1 (en) 2002-07-03 2006-07-27 Pari Gmbh Spezialisten Fur Effektive Inhalation therapy device
US20060102172A1 (en) 2002-10-30 2006-05-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US20060057073A1 (en) 2002-11-08 2006-03-16 Pari Gmbh Wet granulation process
USD483860S1 (en) 2002-11-12 2003-12-16 Pari Gmbh Spezialisten Fur Effektive Inhalation Electronic inhaler and control unit
US7051731B1 (en) 2002-11-15 2006-05-30 Rogerson L Keith Oxygen delivery system
US7077126B2 (en) 2003-05-19 2006-07-18 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy mask and device for animals
US20040250816A1 (en) 2003-05-19 2004-12-16 Pari Gmbh Spezialisten Fur Effective Inhalation Inhalation therapy mask and device for animals
US20050244339A1 (en) 2003-10-15 2005-11-03 Pari Gmbh Pharmaceutical aerosol composition
US20060065267A1 (en) 2004-03-18 2006-03-30 Pari Innovative Manufacturers, Inc. Breath enhanced nebulizer with interchangeable top portions
US20050224076A1 (en) 2004-04-07 2005-10-13 Pari Gmbh Spezialisten Fur Effektive Inhalation Aerosol generation device and inhalation device therewith
US20060048772A1 (en) 2004-08-27 2006-03-09 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device
US20060213503A1 (en) 2005-02-07 2006-09-28 Pari Gmbh Spezialisten Fuer Effektive Inhalation Inhalation therapy device that can be actuated in different modes
US20060207591A1 (en) 2005-02-11 2006-09-21 Pari Gmbh Spezialisten Fuer Effektive Inhalation Aerosol generating means for inhalation therapy devices
US20060254578A1 (en) 2005-05-13 2006-11-16 Pari Gmbh Spezialisten Fuer Effektive Inhalation Inhalation therapy device with a nebulising nozzle and a compressor
US20060289002A1 (en) 2005-06-24 2006-12-28 Pari Gmbh Spezialisten Fur Effektive Inhalation Inhalation therapy device

Non-Patent Citations (24)

* Cited by examiner, † Cited by third party
Title
"AARC Clinical Practice Guideline: Use of Positive Airway Pressure Adjuncts to Bronchial Hygiene Therapy", Respiratory Care, May 1993, vol. 38 No. 5, pp. 516-520.
"Technology Showcase Adjuncts to Bronchial Hygiene Therapy", AARC Times, May 1998, 2 pages.
Application as filed for U.S. Appl. No. 09/287,997, filed Apr. 7, 1999, 65 pages.
Barry, Peter W. et al., "The output of budesonide from spacer devices assessed under simulated breathing conditions," Journal Allergy Clin. Immunol., vol. 104, No. 6, Dec. 1999, pp. 1205-1210.
Callahan, Thomas J., Ph.D., "K981944-BreatheRite," letter from Dept. of Health & Human Services, with enclosure, Aug. 24, 1998, 3 pages.
Claims as filed for U.S. Appl. No. 08/938,686, filed Sep. 26, 1997, 8 pages.
E.F. Christensen et al., "Treatment of Bronchial Asthma with Terbutaline Inhaled by Conespacer Combined With Positive Expiratory Pressure Mask", Chest 100, vol. 2, 1991, pp. 317-321.
E.F. Christensen et al., "Treatment of Bronchial Asthma with Terbutaline Inhaled by Conespacer Combined With Positive Expiratory Pressure Mask", Chest 100, vol. 2, Aug. 1991, pp. 317-321.
Hickey et al., Aerosol Generation from Propellant-Driven Metered Dose Inhalers, Title and Source Unknown, pp. 417-435.
International Search Report for PCT/IB 01/00599 dated Nov. 9, 2001, 8 pages.
J.B. Andersen et al., "A new Mode of Administration of Nebulized Bronchodilator in Severe Bronchospasm", Eur. J. Respir Dis Suppl 119, vol. 63, 1982, pp. 97-100.
J.L. Rau et al., "Combining a Positive Expiratory Pressure Device with a Metered-Dose Inhaler Reservoir System Using Chlorofluorocarbon Albuterol and Hydrofluoroalkane Albuterol: Effect on Dose and Particle Size Distributions", Respiratory Care, Mar. 2000, vol. 45 No. 3, pp. 320-326.
J.L. Rau, Respiratory Care Pharmacology, 4th ed. (1994, Mosby), pp. 256-261.
K. Meeran et al., "Oral and Inhaled Corticosteroids Reduce Bone Formation as Shown by Plasma Osteocalcin Levels", American J. Respir. Crit. Care Med 151:333-336.
M.J. Mahlmeister et al., "Positive -Expiratory-Pressure Mask Therapy: Theoretical and Practical Considerations and a Review of the Literature", Respiratory Care Nov. 1991, vol. 36, No. 11, pp. 1218-1229.
Merriam-Webster's Collegiate Dictionary, Tenth Ed., p. 86, ISBN 0-87779-707-2, Sep. 1993.
Pamphlet for "PARI PEP System", Part No. 18F61, published prior to Apr. 11, 2001, 3 pages.
Pamphlet for "TheraPEP:Positive Expiratory Pressure Therapy System", Catalog No. 20-1112, published prior to Apr. 11, 2001, 4 pages.
Photographs of Ventlab BreatheRite holding chamber, Dec. 2000, 3 pages.
R. Wilson, "Positive Expiratory Pressure Therapy: The Key to Effective, Low-cost Removal of Bronchial Secretions", The Journal for Respiratory Care Practitioners, Mar. 1999, pp. 67-68.
Request for Inter Partes Reexamination of US Patent No. 7,562,656, issued Jul. 21, 2009, dated Aug. 3, 2009, 121 pages.
Respironics® OptiChamber Advantage chart, date unknown, 2 pages.
S.P. Newman, Aerosol Deposition Consideration in Inhalation Therapy, Chest/88/2/Aug. 1985/ [Supplement], pp. 152s-160s.
Ventlab Corporation, "Ventlab BreatheRite," Web page from http://www.ventlab.com/mdi.htm, Dec. 15, 2000, 2 pages.

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881816B2 (en) 2002-05-21 2021-01-05 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
US9814849B2 (en) 2002-05-21 2017-11-14 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
US9364621B2 (en) * 2010-09-21 2016-06-14 Koninklijke Philips N.V. Valved holding chamber including valve retention system
US20130186393A1 (en) * 2010-09-21 2013-07-25 Koninklijke Philips Electronics N.V. Valved holding chamber including valve retention system
USD797922S1 (en) 2013-02-14 2017-09-19 Clement Clarke International Limited Spacer for inhaler
USD744636S1 (en) * 2013-02-14 2015-12-01 Clement Clarke International Limited Spacer for inhaler
USD778432S1 (en) 2013-02-14 2017-02-07 Clement Clarke International Limited Spacer for inhaler
USD760952S1 (en) * 2013-12-10 2016-07-05 Michael James Mayor Electronic cigarette tank with fill port and plug
USD724592S1 (en) * 2014-02-21 2015-03-17 Amazon Technologies, Inc. Scanner device
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery
USD807320S1 (en) * 2015-05-19 2018-01-09 Gibson Innovations Belgium Nv Portable bluetooth speaker
USD866559S1 (en) * 2016-11-11 2019-11-12 Samsung Electronics Co., Ltd. SSD storage device
USD886770S1 (en) * 2017-10-09 2020-06-09 Sunchon Development (Shenzhen) Co., Ltd. Sound box
USD853984S1 (en) * 2017-11-10 2019-07-16 Scosche Industries, Inc. Wireless mobile speaker
US11577033B2 (en) 2018-06-05 2023-02-14 Medline Industries, Lp Valved spacer for inhalation device
USD990447S1 (en) * 2018-06-29 2023-06-27 Logitech Europe S.A. Portable speaker

Also Published As

Publication number Publication date
US6557549B2 (en) 2003-05-06
CA2919286A1 (en) 2001-10-18
USRE46050E1 (en) 2016-07-05
US20020029779A1 (en) 2002-03-14
AU4867001A (en) 2001-10-23
WO2001076671A3 (en) 2002-04-04
CA2733850A1 (en) 2001-10-18
DE60114393D1 (en) 2005-12-01
WO2001076671A2 (en) 2001-10-18
CA2406185C (en) 2011-03-15
US20030226562A1 (en) 2003-12-11
US6848443B2 (en) 2005-02-01
CA2733850C (en) 2013-10-22
CA2826724C (en) 2016-02-02
CA2406185A1 (en) 2001-10-18
CA2826724A1 (en) 2001-10-18
USRE43174E1 (en) 2012-02-14
EP1272243B1 (en) 2005-10-26
EP1272243A2 (en) 2003-01-08
DE60114393T2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
USRE46050E1 (en) Aerosol delivery apparatus
JP3246945B2 (en) Aerosol inhaler
JP4485351B2 (en) Flow display device and supply device provided with flow display device
EP0938908B1 (en) Metered dose inhaler cloud chamber
EP2678060B1 (en) Spacer and components therefor
JP5147406B2 (en) Improved spacer
US4210155A (en) Inspirational inhalation spirometer apparatus
US7013896B2 (en) Mask with inhalation valve
US8678005B2 (en) Adjustable tracheostomy valve
EA005171B1 (en) Sealed back pressure breathing device
MXPA04008162A (en) Inhaler having spacer, lever mechanism and flexible mouthpiece.
EP0050654A1 (en) Inhalation spirometric device for administering pulmonary medication.
EP2014325B1 (en) One-way diaphragm valve for aerosol inhalation system for aerosol pulmonary delivery
WO1999021602A1 (en) Face mask assembly
US20080190420A1 (en) Aerosol Medication Delivery Apparatus
US11577033B2 (en) Valved spacer for inhalation device

Legal Events

Date Code Title Description
CC Certificate of correction